<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:fe934c02-0f8a-4ed7-a34b-dc83a10c16ca,g:614f7be4-2a92-4ccb-bdb9-9746f3ab660f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://c4therapeutics.com/role/Cover" xlink:type="simple" xlink:href="cccc-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_082ca317-41a6-47ef-a7c7-d722b9c82e36" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentType_082ca317-41a6-47ef-a7c7-d722b9c82e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a5653d48-47ba-4140-8152-9c6fe1875da3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentAnnualReport_a5653d48-47ba-4140-8152-9c6fe1875da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_af898139-6a5b-4884-bd92-a2a56d110b2b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentPeriodEndDate_af898139-6a5b-4884-bd92-a2a56d110b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2b9f8735-acb6-4394-b370-e8f77b2d4ddd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_CurrentFiscalYearEndDate_2b9f8735-acb6-4394-b370-e8f77b2d4ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bd068341-61ab-4762-896a-4f1555c384d2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentFiscalYearFocus_bd068341-61ab-4762-896a-4f1555c384d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_215acfdf-bcd3-4fd1-84fd-aa2ac4b8d2fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentFiscalPeriodFocus_215acfdf-bcd3-4fd1-84fd-aa2ac4b8d2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4e6a674a-937b-4545-9cd5-d564f825b201" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentTransitionReport_4e6a674a-937b-4545-9cd5-d564f825b201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3ac6086a-a89a-4c3f-b003-af53f6d6845e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityFileNumber_3ac6086a-a89a-4c3f-b003-af53f6d6845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_263a0782-118e-4c2f-8939-06067e6d0bdb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityRegistrantName_263a0782-118e-4c2f-8939-06067e6d0bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_31f3c278-05a8-4893-aece-a55255ad95ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityIncorporationStateCountryCode_31f3c278-05a8-4893-aece-a55255ad95ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2ea2e012-1a3d-4033-9270-32c7db60a1d9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityTaxIdentificationNumber_2ea2e012-1a3d-4033-9270-32c7db60a1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9a6a0fc3-44cf-4346-b6bb-3e45481cbe6b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityAddressAddressLine1_9a6a0fc3-44cf-4346-b6bb-3e45481cbe6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a3c3e30e-e376-49e4-83c8-bafe8caa53fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityAddressAddressLine2_a3c3e30e-e376-49e4-83c8-bafe8caa53fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9f4d852e-f777-44ae-9470-35b921778f84" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityAddressCityOrTown_9f4d852e-f777-44ae-9470-35b921778f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e8a962f6-6a0d-462d-a8e8-fa6acb396ccd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityAddressStateOrProvince_e8a962f6-6a0d-462d-a8e8-fa6acb396ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_72af4c47-48e5-4c34-9b6f-e47aae2980bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityAddressPostalZipCode_72af4c47-48e5-4c34-9b6f-e47aae2980bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ff2d3c03-8666-4a7e-886b-24c9cc720300" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_CityAreaCode_ff2d3c03-8666-4a7e-886b-24c9cc720300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2432dd67-2d76-40e0-927e-6a1bac01c17c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_LocalPhoneNumber_2432dd67-2d76-40e0-927e-6a1bac01c17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3e1538ac-8f46-4b27-b462-8b2fa355765c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_Security12bTitle_3e1538ac-8f46-4b27-b462-8b2fa355765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9fdc3d7b-d89d-4a3d-8fbf-e75947517b7c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_TradingSymbol_9fdc3d7b-d89d-4a3d-8fbf-e75947517b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_452ae8ca-86b6-4e93-983c-090d80cb2be8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_SecurityExchangeName_452ae8ca-86b6-4e93-983c-090d80cb2be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_c88df110-a27c-4f39-9570-4ee6cb851bfd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_c88df110-a27c-4f39-9570-4ee6cb851bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_0eefd3ee-c777-45c0-85f2-6e3569a1603f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityVoluntaryFilers_0eefd3ee-c777-45c0-85f2-6e3569a1603f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bcce5bec-5032-4de1-94c1-ba804faf6bfa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityCurrentReportingStatus_bcce5bec-5032-4de1-94c1-ba804faf6bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_74d80c43-7f2f-4cfe-ba9c-ae4cd10e7100" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityInteractiveDataCurrent_74d80c43-7f2f-4cfe-ba9c-ae4cd10e7100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_54a3dab4-a9f9-44e0-8aac-67fa26036b66" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityFilerCategory_54a3dab4-a9f9-44e0-8aac-67fa26036b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3acae118-dcde-4e6b-9a98-e75f7b10e1f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntitySmallBusiness_3acae118-dcde-4e6b-9a98-e75f7b10e1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_33e8472c-5bf2-4fe2-be49-cf5dee447e1c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityEmergingGrowthCompany_33e8472c-5bf2-4fe2-be49-cf5dee447e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_8a144ce0-b2b2-487f-a8d7-eb813173010d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_IcfrAuditorAttestationFlag_8a144ce0-b2b2-487f-a8d7-eb813173010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_00ff22c1-85cd-4531-a150-dbe4079fdf2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_00ff22c1-85cd-4531-a150-dbe4079fdf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f25bc717-e222-4708-9d82-e506c1888f41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityShellCompany_f25bc717-e222-4708-9d82-e506c1888f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_b1daa49b-3283-46d5-b8ef-df5b8b349941" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityPublicFloat_b1daa49b-3283-46d5-b8ef-df5b8b349941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_811c02dc-c7c8-4d0d-b9a0-9676c087b2f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_811c02dc-c7c8-4d0d-b9a0-9676c087b2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_01154f79-e684-4dbc-b418-b2cc5ebc130e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_AmendmentFlag_01154f79-e684-4dbc-b418-b2cc5ebc130e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e833ae55-f8af-4d3b-89f8-34a6e3631380" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_EntityCentralIndexKey_e833ae55-f8af-4d3b-89f8-34a6e3631380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4887c371-72b7-42e5-8f6a-855c3dcf4fab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f3d6c780-6840-4454-a778-dc96b0d64743" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4887c371-72b7-42e5-8f6a-855c3dcf4fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AuditInformation" xlink:type="simple" xlink:href="cccc-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AuditInformationAbstract_240cf12a-2c52-4eba-bd05-32fbc56c1c47" xlink:href="cccc-20231231.xsd#cccc_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_278123c7-69ba-4456-83c3-0d094eabd87c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_240cf12a-2c52-4eba-bd05-32fbc56c1c47" xlink:to="loc_dei_AuditorFirmId_278123c7-69ba-4456-83c3-0d094eabd87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_221bc659-03da-4d9f-bfb3-55c015660a3b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_240cf12a-2c52-4eba-bd05-32fbc56c1c47" xlink:to="loc_dei_AuditorName_221bc659-03da-4d9f-bfb3-55c015660a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_2fcd0b8e-bc66-438e-81d3-655b0bc62b70" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_240cf12a-2c52-4eba-bd05-32fbc56c1c47" xlink:to="loc_dei_AuditorLocation_2fcd0b8e-bc66-438e-81d3-655b0bc62b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d69acf23-36b4-462d-87ab-17a93152eb88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d69acf23-36b4-462d-87ab-17a93152eb88" xlink:to="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24a2831e-fff3-4912-85ac-65759f2ab656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24a2831e-fff3-4912-85ac-65759f2ab656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_9edd0ec7-de71-4669-a33a-ba0245fd3983" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_9edd0ec7-de71-4669-a33a-ba0245fd3983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a5055bab-8194-4674-99bd-9c14726eba41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a5055bab-8194-4674-99bd-9c14726eba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e64c2141-3d35-4440-b3a5-5920c9242f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e64c2141-3d35-4440-b3a5-5920c9242f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_75388386-1036-42b0-9029-2b0128d004a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_696714e6-80ef-41d9-9fd9-c9e818fab1ed" xlink:to="loc_us-gaap_AssetsCurrent_75388386-1036-42b0-9029-2b0128d004a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_705fade6-de92-438e-935a-134f33046be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_705fade6-de92-438e-935a-134f33046be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_68ad1898-4dac-4c14-ad91-38bd1ff3b991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_68ad1898-4dac-4c14-ad91-38bd1ff3b991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_26e5013b-5d6d-4d39-9efe-62c4d15a7505" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_26e5013b-5d6d-4d39-9efe-62c4d15a7505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a13093d4-4f05-474c-839d-8f87c1f99aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a13093d4-4f05-474c-839d-8f87c1f99aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d64322c1-8977-400a-8963-f29ac0c8705c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d64322c1-8977-400a-8963-f29ac0c8705c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7a7ee200-fc23-4fc3-bdc2-b07914357cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_add728ea-843f-4252-86df-07ed82235ad3" xlink:to="loc_us-gaap_Assets_7a7ee200-fc23-4fc3-bdc2-b07914357cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d69acf23-36b4-462d-87ab-17a93152eb88" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_205bab44-bc95-4fd6-ab36-e9006f7635f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_AccountsPayableCurrent_205bab44-bc95-4fd6-ab36-e9006f7635f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_b599b738-260d-42bf-823b-b11a03f76671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_b599b738-260d-42bf-823b-b11a03f76671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00a3ab65-6337-4611-94da-a856fe51f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00a3ab65-6337-4611-94da-a856fe51f9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_918e76c0-81df-49a7-8148-2286e17ffc02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_918e76c0-81df-49a7-8148-2286e17ffc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_cc8a015b-3721-4aca-91d7-927612e0be57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_LongTermDebtCurrent_cc8a015b-3721-4aca-91d7-927612e0be57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5338c010-39a2-4e28-9939-4df484e30430" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_910fec4b-f222-4c11-b66b-e264728005f7" xlink:to="loc_us-gaap_LiabilitiesCurrent_5338c010-39a2-4e28-9939-4df484e30430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f9ab8df6-ccbe-4bc9-8e1c-d106f0aca326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f9ab8df6-ccbe-4bc9-8e1c-d106f0aca326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6ec3bb58-3afc-4cac-99c9-2ee6a36d324c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6ec3bb58-3afc-4cac-99c9-2ee6a36d324c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eca75724-93aa-4edf-ad51-3d17ae52bdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eca75724-93aa-4edf-ad51-3d17ae52bdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4c854fc2-e818-404d-af83-86fc5056c6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_Liabilities_4c854fc2-e818-404d-af83-86fc5056c6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_25457e42-49be-4849-85bf-1d64f3ed9376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_CommitmentsAndContingencies_25457e42-49be-4849-85bf-1d64f3ed9376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_684bcacf-888f-496b-ac63-1df3a4f69b49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_PreferredStockValue_684bcacf-888f-496b-ac63-1df3a4f69b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_870c15c4-da2c-49a5-aa7d-25bb1a154ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_CommonStockValue_870c15c4-da2c-49a5-aa7d-25bb1a154ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_78c243ed-297e-4c7d-8f40-95aba5cd6be5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_78c243ed-297e-4c7d-8f40-95aba5cd6be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69d5d1bf-34cb-4d61-8f51-1d5ba9fa7e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69d5d1bf-34cb-4d61-8f51-1d5ba9fa7e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_faf6b5dc-fb4a-4664-b671-237a59016866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_faf6b5dc-fb4a-4664-b671-237a59016866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9ece91b6-8bed-409d-ad92-0fe62e1c2513" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_439f2638-eef4-4a68-b09b-e0f565dd89d4" xlink:to="loc_us-gaap_StockholdersEquity_9ece91b6-8bed-409d-ad92-0fe62e1c2513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_75f0a445-a530-42a8-a07e-827c2c94bf69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7a29ece-50da-4caa-9caf-3a21bba8cb65" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_75f0a445-a530-42a8-a07e-827c2c94bf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0618e6d8-10f9-4d9b-ac9d-93c5d60c91fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0618e6d8-10f9-4d9b-ac9d-93c5d60c91fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_01a91bf8-8ccd-4840-bc3f-3eea0b3bacb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_01a91bf8-8ccd-4840-bc3f-3eea0b3bacb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_eba76cd0-4b12-4dad-8949-c78c27d8e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_PreferredStockSharesIssued_eba76cd0-4b12-4dad-8949-c78c27d8e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_425a5da3-3934-4f21-9e1a-080e0d898be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_425a5da3-3934-4f21-9e1a-080e0d898be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2aa8712e-dc5d-484b-be6c-b642313d0b29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2aa8712e-dc5d-484b-be6c-b642313d0b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6b1bd1db-d474-491b-9b6c-da49170382b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6b1bd1db-d474-491b-9b6c-da49170382b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_74df84bd-81f7-4998-adfc-7f37d4cf594e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_CommonStockSharesIssued_74df84bd-81f7-4998-adfc-7f37d4cf594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2ff82461-ca6e-4907-9a1d-29fadcdab40a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_161964d0-2798-4e14-a161-bfd82b97fc25" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2ff82461-ca6e-4907-9a1d-29fadcdab40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf91e000-08f0-4b07-a013-7992f72e6f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf91e000-08f0-4b07-a013-7992f72e6f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3e2fbb5e-acb8-4761-a6a9-f7b8683a87b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3e2fbb5e-acb8-4761-a6a9-f7b8683a87b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b7dccfbf-5031-4f12-a91c-e8580cc07ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3e2fbb5e-acb8-4761-a6a9-f7b8683a87b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b7dccfbf-5031-4f12-a91c-e8580cc07ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_964fb967-f09e-4f3e-9d7a-0aabcaa79366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3e2fbb5e-acb8-4761-a6a9-f7b8683a87b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_964fb967-f09e-4f3e-9d7a-0aabcaa79366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2f4e8910-4ad1-47fc-a93a-94e4ec8dd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3e2fbb5e-acb8-4761-a6a9-f7b8683a87b7" xlink:to="loc_us-gaap_OperatingExpenses_2f4e8910-4ad1-47fc-a93a-94e4ec8dd40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_230771b1-ace5-4a34-9733-6f9744dafadc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_OperatingIncomeLoss_230771b1-ace5-4a34-9733-6f9744dafadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_1494d791-e687-48fe-ad0f-78684716aab7" xlink:href="cccc-20231231.xsd#cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:to="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_1494d791-e687-48fe-ad0f-78684716aab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_91b09101-bc80-4eef-b519-5a961ec6afdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_91b09101-bc80-4eef-b519-5a961ec6afdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_5efe38eb-bca5-4a42-b19f-edacf984bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:to="loc_us-gaap_InterestAndOtherIncome_5efe38eb-bca5-4a42-b19f-edacf984bc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d6bc578a-1295-4c4f-a202-ebafc0f454ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_40eabff4-89f3-4ae7-80e9-326dc48f9d35" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d6bc578a-1295-4c4f-a202-ebafc0f454ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6df0127a-3b7b-4654-b727-45fcf343cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6df0127a-3b7b-4654-b727-45fcf343cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b021bfc3-32f0-453e-84aa-537db60926dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b021bfc3-32f0-453e-84aa-537db60926dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f9b94ae-2630-4d96-9a34-8c756a3aea29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_NetIncomeLoss_4f9b94ae-2630-4d96-9a34-8c756a3aea29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a525f3b4-1efe-4d8a-8501-3a3950156448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_EarningsPerShareBasic_a525f3b4-1efe-4d8a-8501-3a3950156448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e2497d32-24ba-4564-8cbb-84f5a9a1bd49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e2497d32-24ba-4564-8cbb-84f5a9a1bd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45608c03-05de-4501-946f-86e46189bb91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45608c03-05de-4501-946f-86e46189bb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39d45274-6040-4bd3-a6fc-a310b997c420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39d45274-6040-4bd3-a6fc-a310b997c420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3ee4c88-78b3-43b1-8f7d-182deb7a6816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3ee4c88-78b3-43b1-8f7d-182deb7a6816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_69e5e853-69d2-4d8a-91af-b28b8ae6df8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3ee4c88-78b3-43b1-8f7d-182deb7a6816" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_69e5e853-69d2-4d8a-91af-b28b8ae6df8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d049398c-11a4-43f1-974d-29ae15bc23a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3ee4c88-78b3-43b1-8f7d-182deb7a6816" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d049398c-11a4-43f1-974d-29ae15bc23a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_76d4e652-fbfa-415f-b3bc-2992c5e9f92e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd6d3b4d-8579-4d93-91d6-fad03a916dd6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_76d4e652-fbfa-415f-b3bc-2992c5e9f92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd048585-771b-4d27-b2a9-9747602269a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba94752e-35b2-4bd0-820e-a4817107e618" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd048585-771b-4d27-b2a9-9747602269a9" xlink:to="loc_us-gaap_StatementTable_ba94752e-35b2-4bd0-820e-a4817107e618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_df085719-1e2c-4cde-ab9c-5cc5bfd9bb28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba94752e-35b2-4bd0-820e-a4817107e618" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_df085719-1e2c-4cde-ab9c-5cc5bfd9bb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df085719-1e2c-4cde-ab9c-5cc5bfd9bb28" xlink:to="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d4b4dbef-fb8d-46c8-886d-b09c56fe3988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:to="loc_us-gaap_CommonStockMember_d4b4dbef-fb8d-46c8-886d-b09c56fe3988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4da1271b-5706-44d3-8ad7-57b5276d6bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4da1271b-5706-44d3-8ad7-57b5276d6bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a5b7960d-662d-4ae8-bc7f-bc5032e3c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a5b7960d-662d-4ae8-bc7f-bc5032e3c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dfc5af67-1473-4b63-be36-0da416bac962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3089864c-39d2-4e79-b8e6-99ae58ec6700" xlink:to="loc_us-gaap_RetainedEarningsMember_dfc5af67-1473-4b63-be36-0da416bac962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5d5ddd80-d033-42c9-a5d9-272fdcc86048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba94752e-35b2-4bd0-820e-a4817107e618" xlink:to="loc_us-gaap_StatementLineItems_5d5ddd80-d033-42c9-a5d9-272fdcc86048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d5ddd80-d033-42c9-a5d9-272fdcc86048" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b14a8d0b-1546-4885-b5b5-c94c5d36e6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_SharesOutstanding_b14a8d0b-1546-4885-b5b5-c94c5d36e6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7cba1590-05da-44cd-a883-dc4aa09813c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockholdersEquity_7cba1590-05da-44cd-a883-dc4aa09813c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d28b9659-99e5-46ae-a7c5-7fe7bc32e6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d28b9659-99e5-46ae-a7c5-7fe7bc32e6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4809bdd8-6d1b-468b-9822-b0865d17ed44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4809bdd8-6d1b-468b-9822-b0865d17ed44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c0fc70b9-89ed-489e-affa-1bb91b81e127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c0fc70b9-89ed-489e-affa-1bb91b81e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5e1c9740-da80-4799-9bd9-72511f633ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5e1c9740-da80-4799-9bd9-72511f633ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4a5063ac-db07-423e-8287-d09534e07ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4a5063ac-db07-423e-8287-d09534e07ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_70a4fbeb-5df2-4da9-a240-613f3d6388c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_70a4fbeb-5df2-4da9-a240-613f3d6388c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4681bc93-2043-4f97-8930-a4c6a83e44db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4681bc93-2043-4f97-8930-a4c6a83e44db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7a59be46-9c83-48a7-8034-0375d00604a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7a59be46-9c83-48a7-8034-0375d00604a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_924e90a5-b035-442d-95f4-3174517a4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_924e90a5-b035-442d-95f4-3174517a4e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_44154182-08b4-46d5-b0b1-e408752d4c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_44154182-08b4-46d5-b0b1-e408752d4c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_957530ae-317d-4c24-87be-ff11afc7bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_NetIncomeLoss_957530ae-317d-4c24-87be-ff11afc7bb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_03f45422-b4b9-4947-b085-0c3efa0c8662" xlink:href="cccc-20231231.xsd#cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_03f45422-b4b9-4947-b085-0c3efa0c8662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_89496385-98ba-4f21-af86-7ef1333b5645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_89496385-98ba-4f21-af86-7ef1333b5645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8c10cfdd-a62f-4cef-9ae8-df469be0a465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_SharesOutstanding_8c10cfdd-a62f-4cef-9ae8-df469be0a465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1ffb01f9-533c-4c40-8208-d74d4e099b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4900549f-0523-497d-8b18-f7dc48525edd" xlink:to="loc_us-gaap_StockholdersEquity_1ffb01f9-533c-4c40-8208-d74d4e099b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_801a936c-9361-43ef-a475-3cb6933f74d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_801a936c-9361-43ef-a475-3cb6933f74d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_25060671-306e-49a1-abd8-b098784b5af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_801a936c-9361-43ef-a475-3cb6933f74d2" xlink:to="loc_us-gaap_NetIncomeLoss_25060671-306e-49a1-abd8-b098784b5af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_801a936c-9361-43ef-a475-3cb6933f74d2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f98dc494-864c-4452-9455-755a31f18f97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_ShareBasedCompensation_f98dc494-864c-4452-9455-755a31f18f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_0f27ca2a-18f6-4bc3-b92f-f7f793050dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_DepreciationAndAmortization_0f27ca2a-18f6-4bc3-b92f-f7f793050dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_21e7fa56-6142-4cc9-a0b5-795b6cf5aa2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_21e7fa56-6142-4cc9-a0b5-795b6cf5aa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a2e6898f-b205-4cef-9e80-74425e63617e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a2e6898f-b205-4cef-9e80-74425e63617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_bc3d5060-ed9e-4020-af01-4d2812959941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_bc3d5060-ed9e-4020-af01-4d2812959941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_883d4397-323f-4cd1-abf4-1ae3815d83c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_883d4397-323f-4cd1-abf4-1ae3815d83c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e1543393-b1a2-4a09-b462-6c1a2844ed3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e1543393-b1a2-4a09-b462-6c1a2844ed3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_358fd6cc-0835-41b1-8b6b-d08ef7149c02" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d0b2a115-fdd5-41c6-912b-7a5656d162ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d0b2a115-fdd5-41c6-912b-7a5656d162ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_715b0bf2-9966-43cc-8ca1-63a699166fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_715b0bf2-9966-43cc-8ca1-63a699166fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a87f19c1-7d3c-4c30-8c30-1db26b5c9fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a87f19c1-7d3c-4c30-8c30-1db26b5c9fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_32e57ab4-ec56-4871-9f55-065b05e981f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_32e57ab4-ec56-4871-9f55-065b05e981f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5293574e-4466-431c-96df-672e3229b5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5293574e-4466-431c-96df-672e3229b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b1f50d64-f984-452c-9288-b34b6321eb61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1298a6c6-a2ee-453f-ba30-051ec83d36f7" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b1f50d64-f984-452c-9288-b34b6321eb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39828fb9-1c17-4281-a840-7d921c183cce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_801a936c-9361-43ef-a475-3cb6933f74d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39828fb9-1c17-4281-a840-7d921c183cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_5375e1e5-1bce-4008-9da9-8069d922a6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_5375e1e5-1bce-4008-9da9-8069d922a6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_024d4689-fe0d-4f40-840f-b594220e0fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_024d4689-fe0d-4f40-840f-b594220e0fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e26ed71d-c408-49b2-af15-22bfbad13fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e26ed71d-c408-49b2-af15-22bfbad13fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_82fe595d-f3d3-47b5-8906-6f77155d7d51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_22bcad39-ffce-4dfc-acbf-a073c3f7dd97" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_82fe595d-f3d3-47b5-8906-6f77155d7d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5666b0af-d401-43c3-93d3-84b5d2724aed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5666b0af-d401-43c3-93d3-84b5d2724aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1391d96f-452e-4908-afa0-fdce6aced6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1391d96f-452e-4908-afa0-fdce6aced6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c18db951-79cc-44e1-be28-ff32f574009f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c18db951-79cc-44e1-be28-ff32f574009f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a1db57b3-84e7-4935-99ef-d12fe39817be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a1db57b3-84e7-4935-99ef-d12fe39817be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b68d6358-72db-4857-8122-cf681ed54e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b68d6358-72db-4857-8122-cf681ed54e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c2018d4-5032-441b-aec8-b838f701ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92a16bcf-9b21-4efb-aa78-c9eaac7f0b73" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c2018d4-5032-441b-aec8-b838f701ede0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1ee6bda-de55-4e9c-91ab-5d9dd37f411d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1ee6bda-de55-4e9c-91ab-5d9dd37f411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90323333-1480-4179-84df-26729e9bb8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90323333-1480-4179-84df-26729e9bb8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7c37633-37df-42c8-8d45-6a2e8b3bdf22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7c37633-37df-42c8-8d45-6a2e8b3bdf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ed262d39-8464-4b49-b15d-5c034b7350a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ed262d39-8464-4b49-b15d-5c034b7350a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b7e7d5c-e691-4d03-8606-cad8332b9b73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ed262d39-8464-4b49-b15d-5c034b7350a1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b7e7d5c-e691-4d03-8606-cad8332b9b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_1610ab0c-0b40-4271-96fd-2e5b27a6ac46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ed262d39-8464-4b49-b15d-5c034b7350a1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_1610ab0c-0b40-4271-96fd-2e5b27a6ac46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_794d0560-caf6-4dc0-909b-f9f984a26b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ed262d39-8464-4b49-b15d-5c034b7350a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_794d0560-caf6-4dc0-909b-f9f984a26b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5b02f1ae-b97a-4cc7-a1e5-8a9e4d65fdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5b02f1ae-b97a-4cc7-a1e5-8a9e4d65fdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty_934803ab-9995-403e-9725-f60e89e5ee7f" xlink:href="cccc-20231231.xsd#cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5b02f1ae-b97a-4cc7-a1e5-8a9e4d65fdcb" xlink:to="loc_cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty_934803ab-9995-403e-9725-f60e89e5ee7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_480162ae-d822-4628-a350-05fadbedc133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5b02f1ae-b97a-4cc7-a1e5-8a9e4d65fdcb" xlink:to="loc_us-gaap_InterestPaidNet_480162ae-d822-4628-a350-05fadbedc133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_2fd2f249-42fb-4286-80b5-1410f3172e00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5b02f1ae-b97a-4cc7-a1e5-8a9e4d65fdcb" xlink:to="loc_us-gaap_IncomeTaxesPaid_2fd2f249-42fb-4286-80b5-1410f3172e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_62eae2cf-a3cf-467a-a477-b6b8282e6222" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1d690e5-7bfd-481a-baba-349a506acd3c" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_62eae2cf-a3cf-467a-a477-b6b8282e6222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9779c060-e6eb-470e-9d40-eedaa9764ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_62eae2cf-a3cf-467a-a477-b6b8282e6222" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9779c060-e6eb-470e-9d40-eedaa9764ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_10d29a62-e1a1-4320-8c3e-dd17099eba17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_62eae2cf-a3cf-467a-a477-b6b8282e6222" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_10d29a62-e1a1-4320-8c3e-dd17099eba17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Natureofthebusiness" xlink:type="simple" xlink:href="cccc-20231231.xsd#Natureofthebusiness"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Natureofthebusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3419e569-e236-445b-a057-9a62b561eefc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3830125b-e966-44ce-8143-e0f7fd6badfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3419e569-e236-445b-a057-9a62b561eefc" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3830125b-e966-44ce-8143-e0f7fd6badfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="cccc-20231231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1a4193e1-c403-479c-9e1c-aabbce78387c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b1e0a837-0f83-4ca9-8662-76bcf93e95e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1a4193e1-c403-479c-9e1c-aabbce78387c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b1e0a837-0f83-4ca9-8662-76bcf93e95e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="cccc-20231231.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d52d9bc0-0fd6-4e23-9e16-187d13b4d8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b0d0ed29-333d-4f3f-af44-85421662720e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d52d9bc0-0fd6-4e23-9e16-187d13b4d8ff" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b0d0ed29-333d-4f3f-af44-85421662720e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="simple" xlink:href="cccc-20231231.xsd#Marketablesecurities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_e867ed79-d236-4a81-a5fd-8dedd7663842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_d697a6be-47e4-4c72-9356-52c5b8d9631e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_e867ed79-d236-4a81-a5fd-8dedd7663842" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_d697a6be-47e4-4c72-9356-52c5b8d9631e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="simple" xlink:href="cccc-20231231.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1a2c2801-26ea-448a-afc2-120f3b2fd668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a72d615a-f489-4e29-a0af-c7f673ab02a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1a2c2801-26ea-448a-afc2-120f3b2fd668" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a72d615a-f489-4e29-a0af-c7f673ab02a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Leases" xlink:type="simple" xlink:href="cccc-20231231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3d6c93f0-c1f5-4b1e-8658-d8cb1b403f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_054f0675-4167-404e-972c-d34309b90d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d6c93f0-c1f5-4b1e-8658-d8cb1b403f77" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_054f0675-4167-404e-972c-d34309b90d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="simple" xlink:href="cccc-20231231.xsd#Accruedexpensesandothercurrentliabilities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_304893f1-934f-4364-99b2-b6071b1cd9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_d4d180be-c0f5-4f32-b08a-9bf68405d9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_304893f1-934f-4364-99b2-b6071b1cd9ec" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_d4d180be-c0f5-4f32-b08a-9bf68405d9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="simple" xlink:href="cccc-20231231.xsd#Collaborationandlicenseagreements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f7be5e9-9c12-4ad7-85cd-735d91608dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_2171885f-9978-4ca9-9f64-e8392c96dd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f7be5e9-9c12-4ad7-85cd-735d91608dd9" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_2171885f-9978-4ca9-9f64-e8392c96dd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Longtermdebtandwarrantrelatedparty" xlink:type="simple" xlink:href="cccc-20231231.xsd#Longtermdebtandwarrantrelatedparty"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Longtermdebtandwarrantrelatedparty" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9170cd66-e02a-4035-984a-c86f1ef4bad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantRelatedPartyTextBlock_2f998d2b-e439-44ce-81d6-b0760f86437c" xlink:href="cccc-20231231.xsd#cccc_LongTermDebtAndWarrantRelatedPartyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9170cd66-e02a-4035-984a-c86f1ef4bad3" xlink:to="loc_cccc_LongTermDebtAndWarrantRelatedPartyTextBlock_2f998d2b-e439-44ce-81d6-b0760f86437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="simple" xlink:href="cccc-20231231.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b0528e17-1480-4857-b19f-9faaa91f4c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_89f870bc-7c0b-4c44-ba96-185679122682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b0528e17-1480-4857-b19f-9faaa91f4c7d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_89f870bc-7c0b-4c44-ba96-185679122682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="cccc-20231231.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c72c01d7-81b1-48bc-b7bb-7a1bbaa09dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_60d2c2d8-6e21-4dc4-8f7e-4c78ac826894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c72c01d7-81b1-48bc-b7bb-7a1bbaa09dea" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_60d2c2d8-6e21-4dc4-8f7e-4c78ac826894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Incometaxes" xlink:type="simple" xlink:href="cccc-20231231.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a8827a6f-81d4-4169-be30-438e923c62c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_14f61073-b99d-484f-a989-00512f5382b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8827a6f-81d4-4169-be30-438e923c62c3" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_14f61073-b99d-484f-a989-00512f5382b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Netlosspershare" xlink:type="simple" xlink:href="cccc-20231231.xsd#Netlosspershare"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Netlosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_536e0f8d-b4ff-4e2e-8a9e-7f680942604e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8f962f9a-9f65-460a-b409-28ad411bd9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_536e0f8d-b4ff-4e2e-8a9e-7f680942604e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8f962f9a-9f65-460a-b409-28ad411bd9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Definedcontributionplan" xlink:type="simple" xlink:href="cccc-20231231.xsd#Definedcontributionplan"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Definedcontributionplan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_856ff0a0-074c-462d-80ac-1ecc59205a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_88c083bf-c9ce-4c49-a4ce-abf8bdbf675a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_856ff0a0-074c-462d-80ac-1ecc59205a1a" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_88c083bf-c9ce-4c49-a4ce-abf8bdbf675a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="cccc-20231231.xsd#Commitmentsandcontingencies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Commitmentsandcontingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea960b72-5437-4854-a823-5cecd1aef9db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8d174f71-bf83-4d96-97cd-91b2d07445ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea960b72-5437-4854-a823-5cecd1aef9db" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8d174f71-bf83-4d96-97cd-91b2d07445ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Subsequentevents" xlink:type="simple" xlink:href="cccc-20231231.xsd#Subsequentevents"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Subsequentevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_fbbf15cf-46c3-4aec-b278-602f9f954c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_068ef164-6d21-44c3-a9a9-2659dd4d04a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_fbbf15cf-46c3-4aec-b278-602f9f954c2e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_068ef164-6d21-44c3-a9a9-2659dd4d04a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="cccc-20231231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ae41e382-2f49-4726-a049-53e3e8fe2e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ae41e382-2f49-4726-a049-53e3e8fe2e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_d0d4cbdf-7d3a-4fae-8f34-963a23b44092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_d0d4cbdf-7d3a-4fae-8f34-963a23b44092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ae760039-3cbf-4a6c-a7c6-53c82ec59a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_UseOfEstimates_ae760039-3cbf-4a6c-a7c6-53c82ec59a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9124fba3-e1ce-4e18-9803-eec54ec6394f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9124fba3-e1ce-4e18-9803-eec54ec6394f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_48c4cdfc-3c1f-46ff-bd3c-ce017cd1bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_48c4cdfc-3c1f-46ff-bd3c-ce017cd1bc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8bf97ac6-8bad-4a4f-9f57-e3df1a8d0f65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8bf97ac6-8bad-4a4f-9f57-e3df1a8d0f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_ae39996b-17e9-42f6-b15c-7abcb930254c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_ae39996b-17e9-42f6-b15c-7abcb930254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_9164621e-1634-496e-9362-b20e7bab11be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_9164621e-1634-496e-9362-b20e7bab11be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4631144c-e4f0-4517-b69d-2f270eed1ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4631144c-e4f0-4517-b69d-2f270eed1ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7b369a78-d916-4fc5-8785-a891dc85d285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7b369a78-d916-4fc5-8785-a891dc85d285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ef9cc066-2ad3-4cb4-9987-f770f19a8c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ef9cc066-2ad3-4cb4-9987-f770f19a8c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_78c4c1a9-d02a-40c0-8b67-a99c630e9af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_78c4c1a9-d02a-40c0-8b67-a99c630e9af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_8067158a-0e50-44c0-a5a7-96bc380fae57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_8067158a-0e50-44c0-a5a7-96bc380fae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1b10d557-3d49-4d99-8f32-c2b95f310bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1b10d557-3d49-4d99-8f32-c2b95f310bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_571f5a7b-539e-4698-aa90-404db070b1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_571f5a7b-539e-4698-aa90-404db070b1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_5ba0e51e-18df-44c7-8308-e3a2c8139095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_5ba0e51e-18df-44c7-8308-e3a2c8139095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2398033a-35b5-4add-96d7-2b7b2c76b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_2398033a-35b5-4add-96d7-2b7b2c76b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ea5449a5-c70b-4225-9da1-9cae6efe425d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ea5449a5-c70b-4225-9da1-9cae6efe425d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_e3ede3c0-e37a-4103-9f57-5535df98643a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_e3ede3c0-e37a-4103-9f57-5535df98643a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_GoingConcernPolicyPolicyTextBlock_4b0e9184-20d1-4cd5-99df-f85e00d74472" xlink:href="cccc-20231231.xsd#cccc_GoingConcernPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_cccc_GoingConcernPolicyPolicyTextBlock_4b0e9184-20d1-4cd5-99df-f85e00d74472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1301f8dd-16cd-4dbe-9df3-df23348c77fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3c36fae-d9a9-459b-a4c3-637b6e691170" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1301f8dd-16cd-4dbe-9df3-df23348c77fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7bb4c1bd-a586-4947-9192-505253559a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_91fbf7da-d055-490e-8bbb-2d3d2143122b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7bb4c1bd-a586-4947-9192-505253559a44" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_91fbf7da-d055-490e-8bbb-2d3d2143122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5800b31d-0698-4b21-a206-fd1abe9c94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_699a1571-351e-45c7-87a9-7e63845eda30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5800b31d-0698-4b21-a206-fd1abe9c94bf" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_699a1571-351e-45c7-87a9-7e63845eda30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_8a7221b2-8afe-4357-b342-e5c1161778a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_4843f5da-b1fc-47e6-9d45-894a520a43ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_8a7221b2-8afe-4357-b342-e5c1161778a0" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_4843f5da-b1fc-47e6-9d45-894a520a43ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_77178df3-0a38-4835-8594-74d7b3c77533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_8a7221b2-8afe-4357-b342-e5c1161778a0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_77178df3-0a38-4835-8594-74d7b3c77533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_de7f070b-4735-45bb-95c5-47efc8ee6480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_827bca27-0286-4bb9-8b23-34121157fdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_de7f070b-4735-45bb-95c5-47efc8ee6480" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_827bca27-0286-4bb9-8b23-34121157fdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ScheduleOfDepreciationExpenseTableTableTextBlock_f05566ef-411f-4dfe-9f85-3a28b2414ac1" xlink:href="cccc-20231231.xsd#cccc_ScheduleOfDepreciationExpenseTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_de7f070b-4735-45bb-95c5-47efc8ee6480" xlink:to="loc_cccc_ScheduleOfDepreciationExpenseTableTableTextBlock_f05566ef-411f-4dfe-9f85-3a28b2414ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f0c8e34e-a9ba-474f-8b5e-3c3e9344b3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_2e248f01-a2ee-4d1a-9d89-4348a2d6e932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0c8e34e-a9ba-474f-8b5e-3c3e9344b3ce" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_2e248f01-a2ee-4d1a-9d89-4348a2d6e932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock_eda25407-7497-46ed-acfb-5ca6a1b32075" xlink:href="cccc-20231231.xsd#cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0c8e34e-a9ba-474f-8b5e-3c3e9344b3ce" xlink:to="loc_cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock_eda25407-7497-46ed-acfb-5ca6a1b32075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9d1b4ae8-74da-4b5d-8206-5ac2f2b23ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0c8e34e-a9ba-474f-8b5e-3c3e9344b3ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9d1b4ae8-74da-4b5d-8206-5ac2f2b23ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#AccruedexpensesandothercurrentliabilitiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_119f58b4-5923-4d20-9ad8-83f0891a6cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ed28bbd3-52d3-40ff-85df-87e3597b6b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_119f58b4-5923-4d20-9ad8-83f0891a6cf8" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ed28bbd3-52d3-40ff-85df-87e3597b6b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_281fc919-95c6-4ee6-92c2-eddfeb84e74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_217178c4-23be-4184-8711-5497955e2a88" xlink:href="cccc-20231231.xsd#cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_281fc919-95c6-4ee6-92c2-eddfeb84e74c" xlink:to="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_217178c4-23be-4184-8711-5497955e2a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_09bae3eb-2588-481b-844f-5c6fc54c81d6" xlink:href="cccc-20231231.xsd#cccc_RevenueFromCollaborationAgreementsTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_281fc919-95c6-4ee6-92c2-eddfeb84e74c" xlink:to="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_09bae3eb-2588-481b-844f-5c6fc54c81d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_64614cca-87dd-42b0-adf1-df4beb78a4ba" xlink:href="cccc-20231231.xsd#cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_281fc919-95c6-4ee6-92c2-eddfeb84e74c" xlink:to="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_64614cca-87dd-42b0-adf1-df4beb78a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_23b7ee7f-856d-4e29-b9cf-680f1cfff4e7" xlink:href="cccc-20231231.xsd#cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_281fc919-95c6-4ee6-92c2-eddfeb84e74c" xlink:to="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_23b7ee7f-856d-4e29-b9cf-680f1cfff4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#LongtermdebtandwarrantrelatedpartyTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fa027ff6-6a62-4d02-a7f0-b29f97942878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7e8ff7d1-9fc9-4ef3-9f7a-3299919165fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fa027ff6-6a62-4d02-a7f0-b29f97942878" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7e8ff7d1-9fc9-4ef3-9f7a-3299919165fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f87727d1-2f93-4b20-a3ac-555e625d7ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1a79732c-2860-4637-adf6-554b6a96099d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f87727d1-2f93-4b20-a3ac-555e625d7ce9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1a79732c-2860-4637-adf6-554b6a96099d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1cb053e5-67b2-49a5-bf22-3b42f1a569cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f87727d1-2f93-4b20-a3ac-555e625d7ce9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1cb053e5-67b2-49a5-bf22-3b42f1a569cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_756e4742-76a0-42c9-ba2b-1ca10cf0bf21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f87727d1-2f93-4b20-a3ac-555e625d7ce9" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_756e4742-76a0-42c9-ba2b-1ca10cf0bf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0007b79a-4879-4113-862b-b07948edf5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f87727d1-2f93-4b20-a3ac-555e625d7ce9" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0007b79a-4879-4113-862b-b07948edf5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3b8ce22c-da95-4673-9ec9-b431f9f359de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f2eab081-906a-4212-b18c-eb0a6ebb6235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b8ce22c-da95-4673-9ec9-b431f9f359de" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f2eab081-906a-4212-b18c-eb0a6ebb6235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3e5d9fa4-b07b-4fc5-a7c6-886d2be04a83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b8ce22c-da95-4673-9ec9-b431f9f359de" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3e5d9fa4-b07b-4fc5-a7c6-886d2be04a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3c0201af-a527-40fd-b6cd-22c09eefd34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b8ce22c-da95-4673-9ec9-b431f9f359de" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3c0201af-a527-40fd-b6cd-22c09eefd34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="cccc-20231231.xsd#NetlosspershareTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetlosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6ac0147b-5506-49fd-92c2-29640aaf2f63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_db37fafc-f6e4-46a1-bf8b-57aab25d8fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6ac0147b-5506-49fd-92c2-29640aaf2f63" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_db37fafc-f6e4-46a1-bf8b-57aab25d8fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9819c95c-f3ab-40ea-85e0-2cfa2943129e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6ac0147b-5506-49fd-92c2-29640aaf2f63" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9819c95c-f3ab-40ea-85e0-2cfa2943129e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NatureofthebusinessDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#NatureofthebusinessDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NatureofthebusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7f7f4c4-1132-4b0d-92ff-6d144d921bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6df4bc62-d74c-41a3-8a56-5a6d6bcff579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7f7f4c4-1132-4b0d-92ff-6d144d921bdc" xlink:to="loc_us-gaap_NetIncomeLoss_6df4bc62-d74c-41a3-8a56-5a6d6bcff579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9e42ecd-0349-4ccf-9f1b-ba97bb3028ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7f7f4c4-1132-4b0d-92ff-6d144d921bdc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9e42ecd-0349-4ccf-9f1b-ba97bb3028ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c0d3b650-ca5d-4a8c-8825-3c546a4bac54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7f7f4c4-1132-4b0d-92ff-6d144d921bdc" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c0d3b650-ca5d-4a8c-8825-3c546a4bac54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#SummaryofsignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9a4ab4b3-10a3-42e2-9ecf-f17333478296" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_95a2a831-1f3d-4a11-9564-cc3c5f42cf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a4ab4b3-10a3-42e2-9ecf-f17333478296" xlink:to="loc_us-gaap_NumberOfOperatingSegments_95a2a831-1f3d-4a11-9564-cc3c5f42cf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_e9b50c5c-c50c-44d9-8577-90c2783473b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a4ab4b3-10a3-42e2-9ecf-f17333478296" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_e9b50c5c-c50c-44d9-8577-90c2783473b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c90a3472-577f-4dfa-a974-a90b947175fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_13595120-0029-43c5-be1c-6d1c3b332f50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c90a3472-577f-4dfa-a974-a90b947175fc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_13595120-0029-43c5-be1c-6d1c3b332f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ec3afbd3-3664-4c63-9f9c-ce8965e4ce2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_13595120-0029-43c5-be1c-6d1c3b332f50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ec3afbd3-3664-4c63-9f9c-ce8965e4ce2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512a9c8d-f408-48f3-84a3-2b63ceac162d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ec3afbd3-3664-4c63-9f9c-ce8965e4ce2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512a9c8d-f408-48f3-84a3-2b63ceac162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LaboratoryEquipmentMember_37723a6b-6c5b-41b8-8dc8-ee147082d5f9" xlink:href="cccc-20231231.xsd#cccc_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512a9c8d-f408-48f3-84a3-2b63ceac162d" xlink:to="loc_cccc_LaboratoryEquipmentMember_37723a6b-6c5b-41b8-8dc8-ee147082d5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_299c3879-8084-4fc8-9748-1d8901adbb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512a9c8d-f408-48f3-84a3-2b63ceac162d" xlink:to="loc_us-gaap_ComputerEquipmentMember_299c3879-8084-4fc8-9748-1d8901adbb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OfficeEquipmentFurnitureAndFixturesMember_5935c799-6d1f-4b07-9fd1-db81b34b527f" xlink:href="cccc-20231231.xsd#cccc_OfficeEquipmentFurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512a9c8d-f408-48f3-84a3-2b63ceac162d" xlink:to="loc_cccc_OfficeEquipmentFurnitureAndFixturesMember_5935c799-6d1f-4b07-9fd1-db81b34b527f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6392ac8-5dd8-4172-9113-b7f2045f7b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_13595120-0029-43c5-be1c-6d1c3b332f50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6392ac8-5dd8-4172-9113-b7f2045f7b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_46d61091-49d5-4074-82cc-e20a7498a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6392ac8-5dd8-4172-9113-b7f2045f7b7c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_46d61091-49d5-4074-82cc-e20a7498a5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#FairvaluemeasurementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c0e39414-0b81-4889-8fd4-da66e744dedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0e39414-0b81-4889-8fd4-da66e744dedd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83ce939b-34f2-4509-91f4-b51077c23957" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83ce939b-34f2-4509-91f4-b51077c23957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83abe60f-1fb7-49ca-b7c6-c3fc87ae08ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83ce939b-34f2-4509-91f4-b51077c23957" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83abe60f-1fb7-49ca-b7c6-c3fc87ae08ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a1660f62-e08c-47b9-b970-3f7a4b12ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83abe60f-1fb7-49ca-b7c6-c3fc87ae08ea" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a1660f62-e08c-47b9-b970-3f7a4b12ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5f0b8d06-1f31-4027-ae2d-bd8bd3b3c09a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83abe60f-1fb7-49ca-b7c6-c3fc87ae08ea" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5f0b8d06-1f31-4027-ae2d-bd8bd3b3c09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_79b0c025-cedf-46c0-a519-e0463ea78bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83abe60f-1fb7-49ca-b7c6-c3fc87ae08ea" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_79b0c025-cedf-46c0-a519-e0463ea78bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_b7937a55-6c7e-4ae7-a5f7-3bec4003f874" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_b7937a55-6c7e-4ae7-a5f7-3bec4003f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_32dc9ade-c403-4b49-9444-66f96980df4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_b7937a55-6c7e-4ae7-a5f7-3bec4003f874" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_32dc9ade-c403-4b49-9444-66f96980df4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a4af4a16-44e1-418f-abdb-1a7e357bb19c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_32dc9ade-c403-4b49-9444-66f96980df4c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a4af4a16-44e1-418f-abdb-1a7e357bb19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f56c67e3-cd87-4f2e-a3f1-d024c2adfaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_32dc9ade-c403-4b49-9444-66f96980df4c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f56c67e3-cd87-4f2e-a3f1-d024c2adfaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f0445fd7-281d-485b-92c6-51aaea7ff1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_32dc9ade-c403-4b49-9444-66f96980df4c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f0445fd7-281d-485b-92c6-51aaea7ff1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_56eb7f0b-4422-47f8-b4b2-5c86b24d2e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_56eb7f0b-4422-47f8-b4b2-5c86b24d2e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e0e3f32-242f-4f6f-a924-f9236c0832c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_56eb7f0b-4422-47f8-b4b2-5c86b24d2e94" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e0e3f32-242f-4f6f-a924-f9236c0832c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_72a4b434-5487-4fd4-a8eb-2c802d180288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e0e3f32-242f-4f6f-a924-f9236c0832c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_72a4b434-5487-4fd4-a8eb-2c802d180288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_23f48efb-797e-497e-ae8d-fd011e2cdce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e0e3f32-242f-4f6f-a924-f9236c0832c4" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_23f48efb-797e-497e-ae8d-fd011e2cdce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_60475693-c195-4eb8-b81b-8a45c37e698c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e0e3f32-242f-4f6f-a924-f9236c0832c4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_60475693-c195-4eb8-b81b-8a45c37e698c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f0318a31-ff4c-4067-aefc-0f398589ac32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ba6ae244-6d4d-4015-a1ec-bded16c166d3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f0318a31-ff4c-4067-aefc-0f398589ac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d7883f2f-9d82-45c3-a715-18b8545e8935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f0318a31-ff4c-4067-aefc-0f398589ac32" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d7883f2f-9d82-45c3-a715-18b8545e8935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_6bd21dcf-4436-45e4-a5a4-5bde1e683546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f0318a31-ff4c-4067-aefc-0f398589ac32" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_6bd21dcf-4436-45e4-a5a4-5bde1e683546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_43b9f2a2-820f-4f63-8e25-b15e6114af64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f0318a31-ff4c-4067-aefc-0f398589ac32" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_43b9f2a2-820f-4f63-8e25-b15e6114af64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_f7c1eaee-a5e7-449b-8afa-9c332edc5024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4350600-84ad-4974-ae72-79f76deb8d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_f7c1eaee-a5e7-449b-8afa-9c332edc5024" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4350600-84ad-4974-ae72-79f76deb8d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6fd0a100-8731-4c7c-804c-2678802aebad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4350600-84ad-4974-ae72-79f76deb8d6c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6fd0a100-8731-4c7c-804c-2678802aebad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3a8228a-9dd8-456a-9b86-42f5ed4aa094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6fd0a100-8731-4c7c-804c-2678802aebad" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3a8228a-9dd8-456a-9b86-42f5ed4aa094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3ff14b5a-28aa-4a06-b40b-10f521684cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3a8228a-9dd8-456a-9b86-42f5ed4aa094" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3ff14b5a-28aa-4a06-b40b-10f521684cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_ac24159c-0922-467e-bf39-5fdb9e7432a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3a8228a-9dd8-456a-9b86-42f5ed4aa094" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_ac24159c-0922-467e-bf39-5fdb9e7432a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_e3acc7ae-eb94-4a75-8524-3046e10db612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3a8228a-9dd8-456a-9b86-42f5ed4aa094" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_e3acc7ae-eb94-4a75-8524-3046e10db612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4350600-84ad-4974-ae72-79f76deb8d6c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_aafade8d-5ab2-41c6-b82c-ee80fef76121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_aafade8d-5ab2-41c6-b82c-ee80fef76121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_84bbf46c-fb1d-4402-a8ff-e49aa2f482b9" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_84bbf46c-fb1d-4402-a8ff-e49aa2f482b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_61fef5c3-cee2-4242-9494-dd784f639903" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_61fef5c3-cee2-4242-9494-dd784f639903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_c145b2da-5258-48af-ab43-a8be79151697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_af4e6a69-9ff8-4d6e-82bf-9b12cbc4a496" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_c145b2da-5258-48af-ab43-a8be79151697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a3b5e2ad-9f68-4826-8181-0dea4306d800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a3b5e2ad-9f68-4826-8181-0dea4306d800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_840c37ad-bd47-405d-a1cb-22e0d2a4010b" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_840c37ad-bd47-405d-a1cb-22e0d2a4010b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_1fe805c7-eca8-45ca-af3a-fbea5c60e7e3" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_1fe805c7-eca8-45ca-af3a-fbea5c60e7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_2f8c708a-0ce6-4580-ab4a-44879cbc089c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_b44c3957-4096-4efa-a2ff-0dc20957a7fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_2f8c708a-0ce6-4580-ab4a-44879cbc089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_13815724-0131-47f7-b053-160fe29a61df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_13815724-0131-47f7-b053-160fe29a61df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_19ea92c7-87c9-45f9-a2b9-55c24cb2aa31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_19ea92c7-87c9-45f9-a2b9-55c24cb2aa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c44e5ea4-9be0-4497-8a56-0837f0e61af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c44e5ea4-9be0-4497-8a56-0837f0e61af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_95ca77dd-9e17-4354-b92a-e73632d3f3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_07fc5031-1a2c-43b1-ab1d-34e448603b14" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_95ca77dd-9e17-4354-b92a-e73632d3f3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_716f6181-f322-4e4d-a6bd-20764df7e123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_eeb7f872-1c4d-4c91-af3c-24253be2a6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_716f6181-f322-4e4d-a6bd-20764df7e123" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_eeb7f872-1c4d-4c91-af3c-24253be2a6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ac018394-f419-4dc3-ab85-e5576921902f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_eeb7f872-1c4d-4c91-af3c-24253be2a6fa" xlink:to="loc_us-gaap_InvestmentTypeAxis_ac018394-f419-4dc3-ab85-e5576921902f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_18354964-5bc9-4d53-81dd-4e8cb2c93d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ac018394-f419-4dc3-ab85-e5576921902f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_18354964-5bc9-4d53-81dd-4e8cb2c93d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6be5c69f-86c3-4b4a-9f5a-b1aa1b30172d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_18354964-5bc9-4d53-81dd-4e8cb2c93d3f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6be5c69f-86c3-4b4a-9f5a-b1aa1b30172d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_ba2310c2-a69a-4813-8ca7-906f7545b491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_18354964-5bc9-4d53-81dd-4e8cb2c93d3f" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_ba2310c2-a69a-4813-8ca7-906f7545b491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0f5b23a3-acbe-41cc-94b4-e568ba4244d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_18354964-5bc9-4d53-81dd-4e8cb2c93d3f" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0f5b23a3-acbe-41cc-94b4-e568ba4244d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9e6346a-ca15-4d7f-a6ba-a69ceb1ba1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_eeb7f872-1c4d-4c91-af3c-24253be2a6fa" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9e6346a-ca15-4d7f-a6ba-a69ceb1ba1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_25028f2e-9554-4c80-88a5-4e7ccb5fc483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9e6346a-ca15-4d7f-a6ba-a69ceb1ba1d0" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_25028f2e-9554-4c80-88a5-4e7ccb5fc483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0a5c2061-5038-410a-9aef-17d2e992617e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_25028f2e-9554-4c80-88a5-4e7ccb5fc483" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0a5c2061-5038-410a-9aef-17d2e992617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_2a777514-b4dd-4565-8796-bd5b87d9243b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_25028f2e-9554-4c80-88a5-4e7ccb5fc483" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_2a777514-b4dd-4565-8796-bd5b87d9243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_f6c35410-8d43-4810-98e6-3c3cda21d889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_25028f2e-9554-4c80-88a5-4e7ccb5fc483" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_f6c35410-8d43-4810-98e6-3c3cda21d889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ad31e375-b337-44f5-bed9-94403b5115fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9e6346a-ca15-4d7f-a6ba-a69ceb1ba1d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ad31e375-b337-44f5-bed9-94403b5115fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dabdd77d-c03f-4f72-a7ee-269861d1ed63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ad31e375-b337-44f5-bed9-94403b5115fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dabdd77d-c03f-4f72-a7ee-269861d1ed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_2a879899-af3c-4055-8d03-8d2357f0c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ad31e375-b337-44f5-bed9-94403b5115fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_2a879899-af3c-4055-8d03-8d2357f0c1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_35a3adef-a396-440d-8bf2-274514b6c15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ad31e375-b337-44f5-bed9-94403b5115fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_35a3adef-a396-440d-8bf2-274514b6c15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_58f163be-7b70-483c-93ca-ecca05f8ac2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9e6346a-ca15-4d7f-a6ba-a69ceb1ba1d0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_58f163be-7b70-483c-93ca-ecca05f8ac2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_24a6c778-07a3-4ded-b426-6560baea060e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_58f163be-7b70-483c-93ca-ecca05f8ac2f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_24a6c778-07a3-4ded-b426-6560baea060e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_8497a7df-3439-484d-8cd0-0f4d5852527e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_58f163be-7b70-483c-93ca-ecca05f8ac2f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_8497a7df-3439-484d-8cd0-0f4d5852527e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ab352152-b3b1-422d-9356-c012fb812b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_58f163be-7b70-483c-93ca-ecca05f8ac2f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ab352152-b3b1-422d-9356-c012fb812b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_ace0041b-d80c-4003-841a-c15b8abe49df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_c2efddf1-8d61-4ac9-b842-7d7079979c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_ace0041b-d80c-4003-841a-c15b8abe49df" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_c2efddf1-8d61-4ac9-b842-7d7079979c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#PropertyandequipmentSummaryofpropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c4df957f-7ce4-4388-8355-1c5b1b51581e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a6a4c06d-3cfd-4dda-a2e7-65de20deb458" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c4df957f-7ce4-4388-8355-1c5b1b51581e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a6a4c06d-3cfd-4dda-a2e7-65de20deb458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_68ad0fe8-3600-4162-9bf4-80c284c573a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a6a4c06d-3cfd-4dda-a2e7-65de20deb458" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_68ad0fe8-3600-4162-9bf4-80c284c573a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_68ad0fe8-3600-4162-9bf4-80c284c573a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LaboratoryEquipmentMember_e54f3ce3-2893-4334-bfc2-a64797b4bace" xlink:href="cccc-20231231.xsd#cccc_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_cccc_LaboratoryEquipmentMember_e54f3ce3-2893-4334-bfc2-a64797b4bace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_b27abd6c-b8e7-4202-9ed4-4c49a9af1ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_b27abd6c-b8e7-4202-9ed4-4c49a9af1ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b7a0450f-09e6-4f51-89dd-281f2a4c0d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b7a0450f-09e6-4f51-89dd-281f2a4c0d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_9a3ba9d5-84a5-4caa-a28d-21ba4af14f82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_us-gaap_OfficeEquipmentMember_9a3ba9d5-84a5-4caa-a28d-21ba4af14f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d91993c1-06ed-49e5-ab3d-fba31eeae1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_us-gaap_ComputerEquipmentMember_d91993c1-06ed-49e5-ab3d-fba31eeae1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_fb593d93-6ceb-4058-b236-005b07310537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1d8757e-8ec3-4140-95bd-9e197fa27a70" xlink:to="loc_us-gaap_ConstructionInProgressMember_fb593d93-6ceb-4058-b236-005b07310537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a17ccaa4-1a34-4dca-88e4-25ea38e49e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a6a4c06d-3cfd-4dda-a2e7-65de20deb458" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a17ccaa4-1a34-4dca-88e4-25ea38e49e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_291bca46-247e-4a2a-93e3-152a81ea8c67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a17ccaa4-1a34-4dca-88e4-25ea38e49e3c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_291bca46-247e-4a2a-93e3-152a81ea8c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d73b3a18-fab6-4eba-b370-372dc7ba686a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a17ccaa4-1a34-4dca-88e4-25ea38e49e3c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d73b3a18-fab6-4eba-b370-372dc7ba686a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5dee93dc-5699-44da-b551-dba0d445a8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a17ccaa4-1a34-4dca-88e4-25ea38e49e3c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5dee93dc-5699-44da-b551-dba0d445a8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentSummaryofdepreciationexpenseDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#PropertyandequipmentSummaryofdepreciationexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentSummaryofdepreciationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9e6cf8f6-90ba-4e39-b757-be7c1d165f81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8da6f1fa-4d58-43e4-b2bf-870def490b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9e6cf8f6-90ba-4e39-b757-be7c1d165f81" xlink:to="loc_us-gaap_Depreciation_8da6f1fa-4d58-43e4-b2bf-870def490b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_416b2f4e-86ec-403d-ab82-5e1ea22c652b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4c0d0302-afee-48ac-bc7d-6e52cf81dc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_416b2f4e-86ec-403d-ab82-5e1ea22c652b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4c0d0302-afee-48ac-bc7d-6e52cf81dc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_352310c2-e7e6-46d9-8b84-b802f5b6993a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c0d0302-afee-48ac-bc7d-6e52cf81dc2c" xlink:to="loc_us-gaap_LeaseContractualTermAxis_352310c2-e7e6-46d9-8b84-b802f5b6993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_d339b22e-07f1-4b24-bc49-b8b194f79d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_352310c2-e7e6-46d9-8b84-b802f5b6993a" xlink:to="loc_us-gaap_LeaseContractualTermDomain_d339b22e-07f1-4b24-bc49-b8b194f79d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_WatertownLeaseMember_4b68e529-1dad-497f-8caa-972a85f59946" xlink:href="cccc-20231231.xsd#cccc_WatertownLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_d339b22e-07f1-4b24-bc49-b8b194f79d9f" xlink:to="loc_cccc_WatertownLeaseMember_4b68e529-1dad-497f-8caa-972a85f59946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_607feb34-1b0a-4daf-9509-54b4e8cfa099" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c0d0302-afee-48ac-bc7d-6e52cf81dc2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_607feb34-1b0a-4daf-9509-54b4e8cfa099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d899dbf2-b6b5-4e07-9f67-4adcdc3b7670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_607feb34-1b0a-4daf-9509-54b4e8cfa099" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d899dbf2-b6b5-4e07-9f67-4adcdc3b7670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OfficeAndLaboratorySpaceMember_be3a3221-1acf-4111-a43f-e8aac047d512" xlink:href="cccc-20231231.xsd#cccc_OfficeAndLaboratorySpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d899dbf2-b6b5-4e07-9f67-4adcdc3b7670" xlink:to="loc_cccc_OfficeAndLaboratorySpaceMember_be3a3221-1acf-4111-a43f-e8aac047d512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NewlyLeasedSpaceMember_2a26b220-83af-4bce-9f38-53b6f0108da3" xlink:href="cccc-20231231.xsd#cccc_NewlyLeasedSpaceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d899dbf2-b6b5-4e07-9f67-4adcdc3b7670" xlink:to="loc_cccc_NewlyLeasedSpaceMember_2a26b220-83af-4bce-9f38-53b6f0108da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c0d0302-afee-48ac-bc7d-6e52cf81dc2c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_67ab99ac-3aaa-413c-a234-d4182534e32a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_67ab99ac-3aaa-413c-a234-d4182534e32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LesseeOperatingLeaseNumberOfRenewalOptions_8144c755-2d9e-4e2d-9c72-0cf4a925fdb6" xlink:href="cccc-20231231.xsd#cccc_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_cccc_LesseeOperatingLeaseNumberOfRenewalOptions_8144c755-2d9e-4e2d-9c72-0cf4a925fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f53a7a54-cec9-4215-8eab-130740392906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f53a7a54-cec9-4215-8eab-130740392906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_53b7887e-653f-4572-b374-93326326a4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_OperatingLeaseLiability_53b7887e-653f-4572-b374-93326326a4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c6e3ef53-e5c5-424b-955f-02aa3a81ae32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c6e3ef53-e5c5-424b-955f-02aa3a81ae32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrent_0eae95ae-d576-44d3-aba3-e60469419df4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_ConstructionPayableCurrent_0eae95ae-d576-44d3-aba3-e60469419df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LeaseTermOfAmendedLeaseTerminatePeriod_42dcfa1e-50a0-41c3-bd07-a532a1721ec6" xlink:href="cccc-20231231.xsd#cccc_LeaseTermOfAmendedLeaseTerminatePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_cccc_LeaseTermOfAmendedLeaseTerminatePeriod_42dcfa1e-50a0-41c3-bd07-a532a1721ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_0216fd5b-8cc9-41b7-a1f1-115d3b3c0dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TenantImprovements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_TenantImprovements_0216fd5b-8cc9-41b7-a1f1-115d3b3c0dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_6dca8f35-48d4-401d-9300-efae52f669a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_us-gaap_RestrictedCash_6dca8f35-48d4-401d-9300-efae52f669a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfAmendedLeaseSeparateContracts_8e649605-1fd5-4d47-b85a-8b9fc940d555" xlink:href="cccc-20231231.xsd#cccc_NumberOfAmendedLeaseSeparateContracts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2b6824ff-f707-46db-acfa-a3bd84cfbc6d" xlink:to="loc_cccc_NumberOfAmendedLeaseSeparateContracts_8e649605-1fd5-4d47-b85a-8b9fc940d555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryofleasecostsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3c99bff9-105c-4147-bf85-89d596bf28e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_689b9f02-8416-4aad-a0ab-37f76a9f9b89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c99bff9-105c-4147-bf85-89d596bf28e2" xlink:to="loc_us-gaap_OperatingLeaseCost_689b9f02-8416-4aad-a0ab-37f76a9f9b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_5f31b3b0-c2e9-480d-bbc9-10c2188d128f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c99bff9-105c-4147-bf85-89d596bf28e2" xlink:to="loc_us-gaap_VariableLeaseCost_5f31b3b0-c2e9-480d-bbc9-10c2188d128f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_e2ee5ac2-8bb9-449c-b378-4fbb18e238ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c99bff9-105c-4147-bf85-89d596bf28e2" xlink:to="loc_us-gaap_SubleaseIncome_e2ee5ac2-8bb9-449c-b378-4fbb18e238ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4a2f076a-8399-450f-8298-e78469ce4c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c99bff9-105c-4147-bf85-89d596bf28e2" xlink:to="loc_us-gaap_LeaseCost_4a2f076a-8399-450f-8298-e78469ce4c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryofleasetermandincrementalborrowingrateDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryofleasetermandincrementalborrowingrateDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryofleasetermandincrementalborrowingrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dbd90794-bd6f-46e2-b818-c62d2b78c602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_25da52bd-5797-4791-8c64-331c121c93f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dbd90794-bd6f-46e2-b818-c62d2b78c602" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_25da52bd-5797-4791-8c64-331c121c93f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9678c61e-e83a-41e3-9574-8147411f400e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dbd90794-bd6f-46e2-b818-c62d2b78c602" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9678c61e-e83a-41e3-9574-8147411f400e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryoffutureleasepaymentsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2a6614ec-95ee-41de-b25a-d0cd3ec0dd84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2a6614ec-95ee-41de-b25a-d0cd3ec0dd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c1ae6c2f-1785-4b6a-8ebc-c1964f6a8e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c1ae6c2f-1785-4b6a-8ebc-c1964f6a8e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_65f69237-5ca5-4b5b-9362-9e1bad94eb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_65f69237-5ca5-4b5b-9362-9e1bad94eb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b0b63984-643b-41b2-8ea9-e8a206efa52f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b0b63984-643b-41b2-8ea9-e8a206efa52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_777d4d81-222c-440e-804b-cd151b93a63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_777d4d81-222c-440e-804b-cd151b93a63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_86084646-c6b7-427b-b3a5-ef8712c2836e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_86084646-c6b7-427b-b3a5-ef8712c2836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fc862096-2c2f-4f31-b771-76e7a8f3937c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fc862096-2c2f-4f31-b771-76e7a8f3937c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50da9380-a54f-4874-bcce-809b23daf053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50da9380-a54f-4874-bcce-809b23daf053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_67c05458-7ae8-42ea-bb44-ac556fef4537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a58c3b9e-ecfd-4ec7-95bb-e9e19deebc41" xlink:to="loc_us-gaap_OperatingLeaseLiability_67c05458-7ae8-42ea-bb44-ac556fef4537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryoffutureleasepaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#AccruedexpensesandothercurrentliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AccruedResearchAndDevelopmentCurrent_af479efb-a0b6-407f-947c-e4cd00fadbc4" xlink:href="cccc-20231231.xsd#cccc_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:to="loc_cccc_AccruedResearchAndDevelopmentCurrent_af479efb-a0b6-407f-947c-e4cd00fadbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_af5dfefa-c736-4e5e-b354-d726cc2bede3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_af5dfefa-c736-4e5e-b354-d726cc2bede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_46f54dff-8695-4ba0-8f55-6a4ce5e08472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_46f54dff-8695-4ba0-8f55-6a4ce5e08472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a51d31a4-58e9-4b2e-be35-d3d0bad623ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a51d31a4-58e9-4b2e-be35-d3d0bad623ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AccruedResearchAndDevelopmentWindDownActivities_b2e9027a-45cc-4496-b55d-9e2b03ecec9e" xlink:href="cccc-20231231.xsd#cccc_AccruedResearchAndDevelopmentWindDownActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_878b9555-005f-4278-a559-391e7add7812" xlink:to="loc_cccc_AccruedResearchAndDevelopmentWindDownActivities_b2e9027a-45cc-4496-b55d-9e2b03ecec9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4b82481d-a82f-47f9-941a-9f9ba480fe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4b82481d-a82f-47f9-941a-9f9ba480fe4f" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1b405ee5-7ae3-4828-b0d3-86ac01216adc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1b405ee5-7ae3-4828-b0d3-86ac01216adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1b405ee5-7ae3-4828-b0d3-86ac01216adc" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MerckAgreementMember_af16ae79-61a1-46e8-902d-49c978867f8d" xlink:href="cccc-20231231.xsd#cccc_MerckAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_MerckAgreementMember_af16ae79-61a1-46e8-902d-49c978867f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BettaAgreementMember_3afa7dfa-c613-4c25-a57f-40a3391a7a35" xlink:href="cccc-20231231.xsd#cccc_BettaAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_BettaAgreementMember_3afa7dfa-c613-4c25-a57f-40a3391a7a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementMember_88125bca-00de-4c99-9e19-453d865eeabf" xlink:href="cccc-20231231.xsd#cccc_RestatedRocheAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_RestatedRocheAgreementMember_88125bca-00de-4c99-9e19-453d865eeabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenResearchAndLicenseAgreementMember_460b6761-08fb-4edb-ab7c-205bab522076" xlink:href="cccc-20231231.xsd#cccc_BiogenResearchAndLicenseAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_BiogenResearchAndLicenseAgreementMember_460b6761-08fb-4edb-ab7c-205bab522076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenLicenseAgreementMember_a6f84172-ac31-41d1-9106-e9ac84354d16" xlink:href="cccc-20231231.xsd#cccc_BiogenLicenseAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_BiogenLicenseAgreementMember_a6f84172-ac31-41d1-9106-e9ac84354d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoLicenseAgreementMember_15f96044-eabc-4764-9ea4-0361782ec4a0" xlink:href="cccc-20231231.xsd#cccc_CalicoLicenseAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_CalicoLicenseAgreementMember_15f96044-eabc-4764-9ea4-0361782ec4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember_6d1e5a86-638a-4ec5-a8e6-fdb92847ac8a" xlink:href="cccc-20231231.xsd#cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_625cae3b-d0b4-4546-a075-3e8de63c8eea" xlink:to="loc_cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember_6d1e5a86-638a-4ec5-a8e6-fdb92847ac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1a79789b-9287-4202-b9fc-748db4e9252b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_srt_ProductOrServiceAxis_1a79789b-9287-4202-b9fc-748db4e9252b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1c2640d3-c6ca-44d3-a32f-85029cf363af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1a79789b-9287-4202-b9fc-748db4e9252b" xlink:to="loc_srt_ProductsAndServicesDomain_1c2640d3-c6ca-44d3-a32f-85029cf363af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LeadSeriesIdentificationAchievementMember_39c9a168-b5e5-43ee-958e-d442382f7880" xlink:href="cccc-20231231.xsd#cccc_LeadSeriesIdentificationAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c2640d3-c6ca-44d3-a32f-85029cf363af" xlink:to="loc_cccc_LeadSeriesIdentificationAchievementMember_39c9a168-b5e5-43ee-958e-d442382f7880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b732991e-ac59-423b-8ead-ae5990cddf44" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_srt_RangeAxis_b732991e-ac59-423b-8ead-ae5990cddf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c2a31e5-7fd6-4ac2-a7b5-fc345778a4d0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b732991e-ac59-423b-8ead-ae5990cddf44" xlink:to="loc_srt_RangeMember_5c2a31e5-7fd6-4ac2-a7b5-fc345778a4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a82a298e-8e83-4cd4-921a-a38d4a97e8a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c2a31e5-7fd6-4ac2-a7b5-fc345778a4d0" xlink:to="loc_srt_MinimumMember_a82a298e-8e83-4cd4-921a-a38d4a97e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6ba13c66-48f3-4029-936b-295c8bc9a85a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c2a31e5-7fd6-4ac2-a7b5-fc345778a4d0" xlink:to="loc_srt_MaximumMember_6ba13c66-48f3-4029-936b-295c8bc9a85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_de6a4c70-086b-41a9-9d27-002a36bcaabd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_de6a4c70-086b-41a9-9d27-002a36bcaabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_de6a4c70-086b-41a9-9d27-002a36bcaabd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentMilestonesMember_544e83a4-32ed-4696-a8bb-0d6426dbb5e7" xlink:href="cccc-20231231.xsd#cccc_ResearchAndDevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_ResearchAndDevelopmentMilestonesMember_544e83a4-32ed-4696-a8bb-0d6426dbb5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_99475eb6-bc9f-4fc0-bb2f-a9b2b4fe5369" xlink:href="cccc-20231231.xsd#cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_99475eb6-bc9f-4fc0-bb2f-a9b2b4fe5369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OneTimeSalesBasedPaymentsMember_1c5dcb9c-1534-4e3f-98bb-cc9516013ed7" xlink:href="cccc-20231231.xsd#cccc_OneTimeSalesBasedPaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_OneTimeSalesBasedPaymentsMember_1c5dcb9c-1534-4e3f-98bb-cc9516013ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentServicesMember_7467c987-2d90-4b8a-b867-d284ba3db6be" xlink:href="cccc-20231231.xsd#cccc_ResearchAndDevelopmentServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_ResearchAndDevelopmentServicesMember_7467c987-2d90-4b8a-b867-d284ba3db6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_65d548aa-ad48-4bd5-95b0-19b6fc4b8093" xlink:href="cccc-20231231.xsd#cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_65d548aa-ad48-4bd5-95b0-19b6fc4b8093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DrugApplicationApprovalMember_69221b36-2c0c-48b0-8dc4-a69e104ec489" xlink:href="cccc-20231231.xsd#cccc_DrugApplicationApprovalMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a87f64-979b-4541-be63-42c7c2ab8928" xlink:to="loc_cccc_DrugApplicationApprovalMember_69221b36-2c0c-48b0-8dc4-a69e104ec489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9d3e43b3-1308-444f-ac98-9889cec691be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9d3e43b3-1308-444f-ac98-9889cec691be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8dab0bfb-7596-4355-80d1-521858a7059f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9d3e43b3-1308-444f-ac98-9889cec691be" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8dab0bfb-7596-4355-80d1-521858a7059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_8309d887-a08a-475d-9fbb-38372927f661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8dab0bfb-7596-4355-80d1-521858a7059f" xlink:to="loc_us-gaap_ForeignCountryMember_8309d887-a08a-475d-9fbb-38372927f661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_82995696-a905-491c-a1ea-09293b0b23cb" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontPayment_8bcb0e4d-8ef0-488d-abd5-ab16b70c2ceb" xlink:href="cccc-20231231.xsd#cccc_UpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_UpfrontPayment_8bcb0e4d-8ef0-488d-abd5-ab16b70c2ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_3899d816-20ae-4b89-9d98-1fc92760a395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractsReceivableClaimsAndUncertainAmounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_3899d816-20ae-4b89-9d98-1fc92760a395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionToIncludeNumberOfAdditionalTargets_4103e227-c460-42e3-8870-b5eb98fadda3" xlink:href="cccc-20231231.xsd#cccc_OptionToIncludeNumberOfAdditionalTargets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_OptionToIncludeNumberOfAdditionalTargets_4103e227-c460-42e3-8870-b5eb98fadda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CollaborativeArrangementPotentialProceedsFromCollaboration_bba0800b-83a1-4e46-a909-293254320f35" xlink:href="cccc-20231231.xsd#cccc_CollaborativeArrangementPotentialProceedsFromCollaboration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_CollaborativeArrangementPotentialProceedsFromCollaboration_bba0800b-83a1-4e46-a909-293254320f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_6cd50df0-9c58-48d5-8a1f-243289acc2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_ContractWithCustomerLiability_6cd50df0-9c58-48d5-8a1f-243289acc2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1f8393da-766b-44ae-ac8f-c34d58df37e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1f8393da-766b-44ae-ac8f-c34d58df37e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8e3935f4-e85f-448b-8be2-46385be1bd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8e3935f4-e85f-448b-8be2-46385be1bd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_fc233c97-30ff-4b86-bab2-ac55dd0c6106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_SharePrice_fc233c97-30ff-4b86-bab2-ac55dd0c6106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockRepurchaseProgramPremiumPercentage_4d08a31f-a62d-4709-8bd7-f389c40036e4" xlink:href="cccc-20231231.xsd#cccc_StockRepurchaseProgramPremiumPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_StockRepurchaseProgramPremiumPercentage_4d08a31f-a62d-4709-8bd7-f389c40036e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NoticePeriodForTerminationOfAgreement_c80efb30-6ec2-47a4-86be-a6b9d670c637" xlink:href="cccc-20231231.xsd#cccc_NoticePeriodForTerminationOfAgreement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NoticePeriodForTerminationOfAgreement_c80efb30-6ec2-47a4-86be-a6b9d670c637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CollaborativeArrangementRegulatoryMilestoneAchieved_6b38b078-1e40-426c-abb3-da2176bd1e30" xlink:href="cccc-20231231.xsd#cccc_CollaborativeArrangementRegulatoryMilestoneAchieved"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_CollaborativeArrangementRegulatoryMilestoneAchieved_6b38b078-1e40-426c-abb3-da2176bd1e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PaymentsForTaxWithholdings_8d036c66-ea52-4df8-bc2a-db05880a224b" xlink:href="cccc-20231231.xsd#cccc_PaymentsForTaxWithholdings"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_PaymentsForTaxWithholdings_8d036c66-ea52-4df8-bc2a-db05880a224b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdditionalUpfrontConsideration_a9e63508-a9e0-4b63-bed8-a25b0114582a" xlink:href="cccc-20231231.xsd#cccc_AdditionalUpfrontConsideration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_AdditionalUpfrontConsideration_a9e63508-a9e0-4b63-bed8-a25b0114582a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPotentialTargets_3b0a8e9f-17f2-4589-8e1c-ea5a10676b04" xlink:href="cccc-20231231.xsd#cccc_NumberOfPotentialTargets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NumberOfPotentialTargets_3b0a8e9f-17f2-4589-8e1c-ea5a10676b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargets_a90fbcd9-11a9-413f-ae95-c93e40a7422c" xlink:href="cccc-20231231.xsd#cccc_NumberOfTargets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NumberOfTargets_a90fbcd9-11a9-413f-ae95-c93e40a7422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualResearchPlanPaymentsReceivables_ecbf821e-11cf-448a-bdb4-a83e731b6d9b" xlink:href="cccc-20231231.xsd#cccc_AnnualResearchPlanPaymentsReceivables"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_AnnualResearchPlanPaymentsReceivables_ecbf821e-11cf-448a-bdb4-a83e731b6d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontFees_ee7aa683-e0f6-47c1-91ca-ab6c2e2ac8d2" xlink:href="cccc-20231231.xsd#cccc_UpfrontFees"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_UpfrontFees_ee7aa683-e0f6-47c1-91ca-ab6c2e2ac8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionExerciseFee_dba6a963-6ab3-4c89-9900-d43b3887a7da" xlink:href="cccc-20231231.xsd#cccc_OptionExerciseFee"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_OptionExerciseFee_dba6a963-6ab3-4c89-9900-d43b3887a7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPerformanceObligations_e9072fe2-c3d2-4d9b-8a84-a938962089dd" xlink:href="cccc-20231231.xsd#cccc_NumberOfPerformanceObligations"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NumberOfPerformanceObligations_e9072fe2-c3d2-4d9b-8a84-a938962089dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_082c53f3-5ba4-475d-b4fb-e5c1b4419de2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_082c53f3-5ba4-475d-b4fb-e5c1b4419de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargetedProteinDegradation_56bc3a41-8482-4633-bba2-13eae7564e66" xlink:href="cccc-20231231.xsd#cccc_NumberOfTargetedProteinDegradation"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NumberOfTargetedProteinDegradation_56bc3a41-8482-4633-bba2-13eae7564e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentAgreementPeriod_7dae402f-15e5-4ffa-b5e7-c37b39a7ad42" xlink:href="cccc-20231231.xsd#cccc_ResearchAndDevelopmentAgreementPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_ResearchAndDevelopmentAgreementPeriod_7dae402f-15e5-4ffa-b5e7-c37b39a7ad42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NonRefundableUpfrontPayment_e13ef6df-34fd-499e-ad38-eb54633f25c5" xlink:href="cccc-20231231.xsd#cccc_NonRefundableUpfrontPayment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_NonRefundableUpfrontPayment_e13ef6df-34fd-499e-ad38-eb54633f25c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_b357370b-429f-4943-992b-deb739c83746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_ProceedsFromCollaborators_b357370b-429f-4943-992b-deb739c83746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f393f2dc-a478-4aa3-92d5-f841d4002eef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f393f2dc-a478-4aa3-92d5-f841d4002eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_f554c9d7-8c0c-414a-ab41-48477068fb2a" xlink:href="cccc-20231231.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_f554c9d7-8c0c-414a-ab41-48477068fb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchTerm_4e4831c2-4f0c-4f17-aa28-f8923fff554d" xlink:href="cccc-20231231.xsd#cccc_ResearchTerm"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_ResearchTerm_4e4831c2-4f0c-4f17-aa28-f8923fff554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchExtendedTerm_244d6e66-0e12-4af2-8dbf-e9efd67a2f12" xlink:href="cccc-20231231.xsd#cccc_ResearchExtendedTerm"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_ResearchExtendedTerm_244d6e66-0e12-4af2-8dbf-e9efd67a2f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AmountPayableForExtendResearchTermOption_6846d799-26cb-44e6-83e0-b068bb4018bf" xlink:href="cccc-20231231.xsd#cccc_AmountPayableForExtendResearchTermOption"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_AmountPayableForExtendResearchTermOption_6846d799-26cb-44e6-83e0-b068bb4018bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualPayments_805ed270-59b8-489b-8ae8-bbc71a515e20" xlink:href="cccc-20231231.xsd#cccc_AnnualPayments"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b191d411-7582-4062-9f0e-9a878d83e8cc" xlink:to="loc_cccc_AnnualPayments_805ed270-59b8-489b-8ae8-bbc71a515e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cb6ce85d-a96f-4b16-ac43-ee252f1c5a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_28f77dd8-35a3-44fa-ba54-38bf4965f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cb6ce85d-a96f-4b16-ac43-ee252f1c5a39" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_28f77dd8-35a3-44fa-ba54-38bf4965f15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab704f35-2c2d-4b93-9a5b-fcbb277eed77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_28f77dd8-35a3-44fa-ba54-38bf4965f15a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab704f35-2c2d-4b93-9a5b-fcbb277eed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3bd8e567-1d1d-48f1-8805-681a1ab62d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab704f35-2c2d-4b93-9a5b-fcbb277eed77" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3bd8e567-1d1d-48f1-8805-681a1ab62d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentTargetsMember_388ffff1-9524-4f30-a556-114b96ff47ed" xlink:href="cccc-20231231.xsd#cccc_ResearchAndDevelopmentTargetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3bd8e567-1d1d-48f1-8805-681a1ab62d90" xlink:to="loc_cccc_ResearchAndDevelopmentTargetsMember_388ffff1-9524-4f30-a556-114b96ff47ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionRightsMember_fabe98af-a916-43fa-9328-d145fb514d5e" xlink:href="cccc-20231231.xsd#cccc_OptionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3bd8e567-1d1d-48f1-8805-681a1ab62d90" xlink:to="loc_cccc_OptionRightsMember_fabe98af-a916-43fa-9328-d145fb514d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f8ff12d3-1f6b-4652-8524-2eafab92d106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_28f77dd8-35a3-44fa-ba54-38bf4965f15a" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f8ff12d3-1f6b-4652-8524-2eafab92d106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_fe27dbd4-9038-4bf4-ac4b-39e48bd12212" xlink:href="cccc-20231231.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f8ff12d3-1f6b-4652-8524-2eafab92d106" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_fe27dbd4-9038-4bf4-ac4b-39e48bd12212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_506b4399-3cf8-4029-b8af-c27abd8efcfb" xlink:href="cccc-20231231.xsd#cccc_TransactionPriceUnsatisfiedToPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f8ff12d3-1f6b-4652-8524-2eafab92d106" xlink:to="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_506b4399-3cf8-4029-b8af-c27abd8efcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7dc39f4d-27e5-4567-a04b-079a6eb0ed72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0fae0b6d-baf9-451a-badc-d7b188a761d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7dc39f4d-27e5-4567-a04b-079a6eb0ed72" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0fae0b6d-baf9-451a-badc-d7b188a761d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_935923ab-a97d-4ee2-a89a-9ef172b0a92f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0fae0b6d-baf9-451a-badc-d7b188a761d6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_935923ab-a97d-4ee2-a89a-9ef172b0a92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935923ab-a97d-4ee2-a89a-9ef172b0a92f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_5eca2541-fec3-456b-b051-fca64a09b2f2" xlink:href="cccc-20231231.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:to="loc_cccc_RocheAgreementMember_5eca2541-fec3-456b-b051-fca64a09b2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_f37ff58d-fb1e-41fd-a8fb-62a96319d7b1" xlink:href="cccc-20231231.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:to="loc_cccc_BiogenAgreementMember_f37ff58d-fb1e-41fd-a8fb-62a96319d7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoAgreementMember_fce098a6-47a1-4ccf-97cf-8d24559968a3" xlink:href="cccc-20231231.xsd#cccc_CalicoAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:to="loc_cccc_CalicoAgreementMember_fce098a6-47a1-4ccf-97cf-8d24559968a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BettaAgreementMember_ef7a570e-b48c-448d-8a7a-0320ebb46b3a" xlink:href="cccc-20231231.xsd#cccc_BettaAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cd5264d-7413-4a60-a808-54936a036728" xlink:to="loc_cccc_BettaAgreementMember_ef7a570e-b48c-448d-8a7a-0320ebb46b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f06bc511-3de6-4644-a06e-aa86c27930e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0fae0b6d-baf9-451a-badc-d7b188a761d6" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f06bc511-3de6-4644-a06e-aa86c27930e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_663db9d7-cc60-455c-8fff-7cd19cfe7c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f06bc511-3de6-4644-a06e-aa86c27930e3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_663db9d7-cc60-455c-8fff-7cd19cfe7c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_868dd1ef-259d-41a1-b971-1e7c064bc388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_21905f0b-fc3f-40b4-964f-46cecce91631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_868dd1ef-259d-41a1-b971-1e7c064bc388" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_21905f0b-fc3f-40b4-964f-46cecce91631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cf63b785-9c2e-4fbc-a5a5-8d7bc7fa5933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_21905f0b-fc3f-40b4-964f-46cecce91631" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cf63b785-9c2e-4fbc-a5a5-8d7bc7fa5933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cf63b785-9c2e-4fbc-a5a5-8d7bc7fa5933" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_2113005e-d671-4657-a84f-17b90e953a78" xlink:href="cccc-20231231.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:to="loc_cccc_RocheAgreementMember_2113005e-d671-4657-a84f-17b90e953a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BettaAgreementMember_1399090c-34bc-487d-806f-fd0cdb8bf8e1" xlink:href="cccc-20231231.xsd#cccc_BettaAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:to="loc_cccc_BettaAgreementMember_1399090c-34bc-487d-806f-fd0cdb8bf8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MerckAgreementMember_4c842894-d9b7-4261-b097-c09af2c105dd" xlink:href="cccc-20231231.xsd#cccc_MerckAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:to="loc_cccc_MerckAgreementMember_4c842894-d9b7-4261-b097-c09af2c105dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_a5e0cfe5-fbad-4888-b37b-5dc8a6ca2568" xlink:href="cccc-20231231.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:to="loc_cccc_BiogenAgreementMember_a5e0cfe5-fbad-4888-b37b-5dc8a6ca2568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoAgreementMember_ae09766d-f5b6-45ee-8b02-32507425df00" xlink:href="cccc-20231231.xsd#cccc_CalicoAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_147ac789-26fe-474e-9162-2e769e64f7ef" xlink:to="loc_cccc_CalicoAgreementMember_ae09766d-f5b6-45ee-8b02-32507425df00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_21905f0b-fc3f-40b4-964f-46cecce91631" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7b1f73f7-a85f-4965-8ade-5105c8fa079b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7b1f73f7-a85f-4965-8ade-5105c8fa079b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1636f980-ffa0-4d69-85d0-00be80eb6d50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1636f980-ffa0-4d69-85d0-00be80eb6d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c0bb07e6-b2f4-4b50-8d1e-5b0263560be3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c0bb07e6-b2f4-4b50-8d1e-5b0263560be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_87fddaa1-ed06-412d-9225-7c03110fca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c63b77b5-cee7-48a4-9717-2721873107ff" xlink:to="loc_us-gaap_ContractWithCustomerLiability_87fddaa1-ed06-412d-9225-7c03110fca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_325a9715-6f2b-4d3a-bdfc-7a0fbbc7dfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8c6fda16-b476-4166-b86a-8273a1584e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_325a9715-6f2b-4d3a-bdfc-7a0fbbc7dfbb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8c6fda16-b476-4166-b86a-8273a1584e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_d5249319-a969-440a-9c9f-9cc77ceb9369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_325a9715-6f2b-4d3a-bdfc-7a0fbbc7dfbb" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_d5249319-a969-440a-9c9f-9cc77ceb9369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_11e05d48-7433-408c-8af2-26d0e7eef47b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_887ae375-8f40-4c18-adc7-4e4429d7d7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11e05d48-7433-408c-8af2-26d0e7eef47b" xlink:to="loc_us-gaap_LongTermDebt_887ae375-8f40-4c18-adc7-4e4429d7d7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d367bbe1-a976-4933-9e22-cc21c5315e76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11e05d48-7433-408c-8af2-26d0e7eef47b" xlink:to="loc_us-gaap_LongTermDebtCurrent_d367bbe1-a976-4933-9e22-cc21c5315e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d6dad3c7-b1b7-490c-bd53-99c2c8c053f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11e05d48-7433-408c-8af2-26d0e7eef47b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d6dad3c7-b1b7-490c-bd53-99c2c8c053f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_2f476e1c-7888-4e23-ae10-99dcb740c285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11e05d48-7433-408c-8af2-26d0e7eef47b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_2f476e1c-7888-4e23-ae10-99dcb740c285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyrelatedpartyNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LongtermdebtandwarrantrelatedpartyrelatedpartyNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyrelatedpartyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4a72e02e-d783-426e-974d-a377616dee12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:href="cccc-20231231.xsd#cccc_LongTermDebtAndWarrantLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4a72e02e-d783-426e-974d-a377616dee12" xlink:to="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6951e7c-c1d4-49ef-ba50-58e0330d056d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:to="loc_us-gaap_CreditFacilityAxis_d6951e7c-c1d4-49ef-ba50-58e0330d056d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_dcfc736e-a897-4dc1-bd27-53a764745d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d6951e7c-c1d4-49ef-ba50-58e0330d056d" xlink:to="loc_us-gaap_CreditFacilityDomain_dcfc736e-a897-4dc1-bd27-53a764745d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember_507b877d-bd1f-4883-8f24-ad8aa2629cec" xlink:href="cccc-20231231.xsd#cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_dcfc736e-a897-4dc1-bd27-53a764745d08" xlink:to="loc_cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember_507b877d-bd1f-4883-8f24-ad8aa2629cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0897079-4534-4d22-8184-d86e16144406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0897079-4534-4d22-8184-d86e16144406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a5216473-9cd8-4a65-8c32-cdf74150fdae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0897079-4534-4d22-8184-d86e16144406" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a5216473-9cd8-4a65-8c32-cdf74150fdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TermLoanMember_f54bc55b-8dc8-4489-af36-a17387a84b97" xlink:href="cccc-20231231.xsd#cccc_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a5216473-9cd8-4a65-8c32-cdf74150fdae" xlink:to="loc_cccc_TermLoanMember_f54bc55b-8dc8-4489-af36-a17387a84b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_878b4e18-27da-46cf-83b3-dc22fd6ea43a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_878b4e18-27da-46cf-83b3-dc22fd6ea43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95b721b1-177c-410e-b083-b1e08910a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_878b4e18-27da-46cf-83b3-dc22fd6ea43a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95b721b1-177c-410e-b083-b1e08910a8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TrancheOneMember_4dbcadd5-485b-4d91-96a4-fba8af4b36c3" xlink:href="cccc-20231231.xsd#cccc_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95b721b1-177c-410e-b083-b1e08910a8f6" xlink:to="loc_cccc_TrancheOneMember_4dbcadd5-485b-4d91-96a4-fba8af4b36c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TrancheTwoMember_7acd57aa-87e9-47f6-8117-88cd813e8913" xlink:href="cccc-20231231.xsd#cccc_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95b721b1-177c-410e-b083-b1e08910a8f6" xlink:to="loc_cccc_TrancheTwoMember_7acd57aa-87e9-47f6-8117-88cd813e8913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:href="cccc-20231231.xsd#cccc_LongTermDebtAndWarrantLiabilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_117e8af3-4fa3-4be6-a71d-6f2734c752ac" xlink:to="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dc3d89b6-af1c-43a5-8e6a-daf2ccd649dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dc3d89b6-af1c-43a5-8e6a-daf2ccd649dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9d186d74-5ca3-471f-81b5-0cad383e5917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:to="loc_us-gaap_LineOfCredit_9d186d74-5ca3-471f-81b5-0cad383e5917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_94a3de04-b753-473f-a84c-4a9e6d97dde6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_94a3de04-b753-473f-a84c-4a9e6d97dde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_aa7de095-4f6c-431c-b32c-c19d0a62244d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_6ae35f23-4817-4e91-83ee-939d262a8e8f" xlink:to="loc_us-gaap_InterestExpenseBorrowings_aa7de095-4f6c-431c-b32c-c19d0a62244d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockholdersequityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c1bb363b-6d39-4893-9b3e-4184ce408622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c1bb363b-6d39-4893-9b3e-4184ce408622" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8f0a6b08-abd7-4196-babd-555fd5061295" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:to="loc_srt_RangeAxis_8f0a6b08-abd7-4196-babd-555fd5061295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_51a81626-b028-41cf-b55f-c46ff1ef8114" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8f0a6b08-abd7-4196-babd-555fd5061295" xlink:to="loc_srt_RangeMember_51a81626-b028-41cf-b55f-c46ff1ef8114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bcf225a7-4c68-4ee6-9596-6b2e751a7cfb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_51a81626-b028-41cf-b55f-c46ff1ef8114" xlink:to="loc_srt_MaximumMember_bcf225a7-4c68-4ee6-9596-6b2e751a7cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8006bd25-4654-4cf0-a4f9-3824dc7932d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8006bd25-4654-4cf0-a4f9-3824dc7932d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_81e7edaf-9e32-49f5-b2e1-2356677c14ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8006bd25-4654-4cf0-a4f9-3824dc7932d5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_81e7edaf-9e32-49f5-b2e1-2356677c14ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AtmOfferingsMember_cc3e5fc3-fa5a-49d6-9dd1-bcabd610f69b" xlink:href="cccc-20231231.xsd#cccc_AtmOfferingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_81e7edaf-9e32-49f5-b2e1-2356677c14ef" xlink:to="loc_cccc_AtmOfferingsMember_cc3e5fc3-fa5a-49d6-9dd1-bcabd610f69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7dd3f02b-2fa5-4ceb-9484-bb65877b1172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7dd3f02b-2fa5-4ceb-9484-bb65877b1172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10c8e59d-c62f-48c7-aba1-1b8dd9642f64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7dd3f02b-2fa5-4ceb-9484-bb65877b1172" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10c8e59d-c62f-48c7-aba1-1b8dd9642f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_2d9ae9b3-2a7d-41cb-b08f-f512f25c46ad" xlink:href="cccc-20231231.xsd#cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10c8e59d-c62f-48c7-aba1-1b8dd9642f64" xlink:to="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_2d9ae9b3-2a7d-41cb-b08f-f512f25c46ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_53908d47-c9dc-4d75-9fa6-59a8eee67510" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_53908d47-c9dc-4d75-9fa6-59a8eee67510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d41f7789-322c-46c2-a565-dbf0341d8c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53908d47-c9dc-4d75-9fa6-59a8eee67510" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d41f7789-322c-46c2-a565-dbf0341d8c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9e57140d-6b09-416e-bbaa-e8928a9dcf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d41f7789-322c-46c2-a565-dbf0341d8c7d" xlink:to="loc_us-gaap_SubsequentEventMember_9e57140d-6b09-416e-bbaa-e8928a9dcf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae84f171-dafe-42e9-82b4-f912846af014" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ef735f23-3db6-46d5-a68f-6e422d990cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ef735f23-3db6-46d5-a68f-6e422d990cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bf823004-5e93-4a03-9557-d70e0fc6cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bf823004-5e93-4a03-9557-d70e0fc6cdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_146ad549-3c6c-4080-813c-258ef40b32a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_146ad549-3c6c-4080-813c-258ef40b32a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a37cc583-b4d5-4ff8-8894-4250435c003f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a37cc583-b4d5-4ff8-8894-4250435c003f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CommonStockNumberOfVotesEachShare_81127350-8f4e-427c-83c2-d5feaa4266f4" xlink:href="cccc-20231231.xsd#cccc_CommonStockNumberOfVotesEachShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_cccc_CommonStockNumberOfVotesEachShare_81127350-8f4e-427c-83c2-d5feaa4266f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e2e1bdc7-1162-4e97-9be6-53fa369c2355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e2e1bdc7-1162-4e97-9be6-53fa369c2355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fdb8e128-f140-4da0-8262-9f6457726a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fdb8e128-f140-4da0-8262-9f6457726a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a348dd58-5630-4ce1-a7d1-fde49f1f2927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_07f88873-3172-42d1-87ba-d40fdf3ccd40" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a348dd58-5630-4ce1-a7d1-fde49f1f2927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ac5145-4a61-4808-8935-c77a9bef6418" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ac5145-4a61-4808-8935-c77a9bef6418" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_26f0c6ae-b1af-4673-a30a-653e95cd6c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_PlanNameAxis_26f0c6ae-b1af-4673-a30a-653e95cd6c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b8b8e30b-c413-461d-8777-93718e107ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_26f0c6ae-b1af-4673-a30a-653e95cd6c43" xlink:to="loc_us-gaap_PlanNameDomain_b8b8e30b-c413-461d-8777-93718e107ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember_af8a6a38-f500-4942-a3f2-066c887877f1" xlink:href="cccc-20231231.xsd#cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b8b8e30b-c413-461d-8777-93718e107ad2" xlink:to="loc_cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember_af8a6a38-f500-4942-a3f2-066c887877f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_baa6c9f8-9344-45b4-935b-8cf40c008b22" xlink:href="cccc-20231231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b8b8e30b-c413-461d-8777-93718e107ad2" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_baa6c9f8-9344-45b4-935b-8cf40c008b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember_e9a5c7cf-a69a-4a9e-8200-1bb2a334419f" xlink:href="cccc-20231231.xsd#cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b8b8e30b-c413-461d-8777-93718e107ad2" xlink:to="loc_cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember_e9a5c7cf-a69a-4a9e-8200-1bb2a334419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d12ebe63-c89b-4f9c-bf42-d6c02d408941" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_srt_RangeAxis_d12ebe63-c89b-4f9c-bf42-d6c02d408941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0e56318-f3a6-4008-b334-a76a8dd6f1a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d12ebe63-c89b-4f9c-bf42-d6c02d408941" xlink:to="loc_srt_RangeMember_e0e56318-f3a6-4008-b334-a76a8dd6f1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d2f2a745-0b5f-495c-96cb-acbd1298f774" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e0e56318-f3a6-4008-b334-a76a8dd6f1a6" xlink:to="loc_srt_MinimumMember_d2f2a745-0b5f-495c-96cb-acbd1298f774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f4ec451d-0c68-4364-be7e-83af819b7afd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e0e56318-f3a6-4008-b334-a76a8dd6f1a6" xlink:to="loc_srt_MaximumMember_f4ec451d-0c68-4364-be7e-83af819b7afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5ce547e8-75fd-476f-8682-0837588ba6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_AwardTypeAxis_5ce547e8-75fd-476f-8682-0837588ba6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcfbc237-e1b9-42c1-9107-19a0ec14e897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5ce547e8-75fd-476f-8682-0837588ba6fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcfbc237-e1b9-42c1-9107-19a0ec14e897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bfa5d690-631d-4c7f-9fad-12b80fa0ea49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcfbc237-e1b9-42c1-9107-19a0ec14e897" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bfa5d690-631d-4c7f-9fad-12b80fa0ea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TimeBasedRestrictedStockUnitsMember_6b4f0aea-e080-4a6b-b76c-b1b71664c8d2" xlink:href="cccc-20231231.xsd#cccc_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcfbc237-e1b9-42c1-9107-19a0ec14e897" xlink:to="loc_cccc_TimeBasedRestrictedStockUnitsMember_6b4f0aea-e080-4a6b-b76c-b1b71664c8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_deb7afcc-59c7-45fe-b8d2-b7926a787410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcfbc237-e1b9-42c1-9107-19a0ec14e897" xlink:to="loc_us-gaap_EmployeeStockOptionMember_deb7afcc-59c7-45fe-b8d2-b7926a787410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_75d31f8f-b677-4968-a08f-a345b3dd08c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_75d31f8f-b677-4968-a08f-a345b3dd08c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_40ce73ce-ac4b-4ed7-8535-efe7a41b6cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_75d31f8f-b677-4968-a08f-a345b3dd08c7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_40ce73ce-ac4b-4ed7-8535-efe7a41b6cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_44324479-4da5-4bd1-af2e-b53c05584646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_40ce73ce-ac4b-4ed7-8535-efe7a41b6cbf" xlink:to="loc_us-gaap_SubsequentEventMember_44324479-4da5-4bd1-af2e-b53c05584646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_3e3c0efc-d196-4717-8cd8-252532b79119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_GranteeStatusAxis_3e3c0efc-d196-4717-8cd8-252532b79119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_387beac5-f299-463f-ab94-fe159f29f6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_3e3c0efc-d196-4717-8cd8-252532b79119" xlink:to="loc_us-gaap_GranteeStatusDomain_387beac5-f299-463f-ab94-fe159f29f6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_047399b7-709e-4511-9ad9-0362ee327669" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_387beac5-f299-463f-ab94-fe159f29f6f1" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_047399b7-709e-4511-9ad9-0362ee327669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_5c38cff2-fcc9-4822-ae33-5fef74618ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_VestingAxis_5c38cff2-fcc9-4822-ae33-5fef74618ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_dc9316b9-4861-414c-80ae-aa194a894c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_5c38cff2-fcc9-4822-ae33-5fef74618ed0" xlink:to="loc_us-gaap_VestingDomain_dc9316b9-4861-414c-80ae-aa194a894c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8f31a777-f294-4c4f-8ce4-2030efebb048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_dc9316b9-4861-414c-80ae-aa194a894c6e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8f31a777-f294-4c4f-8ce4-2030efebb048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c4e7cb1a-276c-4a79-b295-9b092b8efa21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_dc9316b9-4861-414c-80ae-aa194a894c6e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c4e7cb1a-276c-4a79-b295-9b092b8efa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2f48da6-81ac-42e1-8ac7-e0d9c040aa90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_47ccaf7d-aa53-46be-a450-34a4115af396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_47ccaf7d-aa53-46be-a450-34a4115af396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0ad8332e-8975-4664-b173-3f842c3141b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0ad8332e-8975-4664-b173-3f842c3141b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod_8345aed8-14e0-4568-b37a-acecaeda1deb" xlink:href="cccc-20231231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod_8345aed8-14e0-4568-b37a-acecaeda1deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_766186c1-8323-49d7-8687-d42ad2966666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_766186c1-8323-49d7-8687-d42ad2966666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_71ad6352-9232-4ba5-a4ac-a084181153cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_71ad6352-9232-4ba5-a4ac-a084181153cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PercentageOfOutstandingSharesOfCommonStock_d4e11f9f-1b59-4953-beb1-ab5c23d13695" xlink:href="cccc-20231231.xsd#cccc_PercentageOfOutstandingSharesOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_cccc_PercentageOfOutstandingSharesOfCommonStock_d4e11f9f-1b59-4953-beb1-ab5c23d13695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9446d5e1-983c-41f8-ae5e-135f2c3a2c07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9446d5e1-983c-41f8-ae5e-135f2c3a2c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3a2f2b25-fb0f-4395-befd-f9e8486105de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3a2f2b25-fb0f-4395-befd-f9e8486105de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_21758f0c-61be-4e32-b0c6-b352b0c64133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_21758f0c-61be-4e32-b0c6-b352b0c64133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dd24d333-b3f7-4941-98f6-aad0c23c61dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dd24d333-b3f7-4941-98f6-aad0c23c61dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested_5d31f9b1-1817-4020-9c9e-ab8b8fb71af9" xlink:href="cccc-20231231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested_5d31f9b1-1817-4020-9c9e-ab8b8fb71af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_7a57a54d-d9fa-445b-9a2f-bf4312dcdafc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_7a57a54d-d9fa-445b-9a2f-bf4312dcdafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c36ca039-3ff8-43a4-8789-edc317cec369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c36ca039-3ff8-43a4-8789-edc317cec369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees_6d3bd792-3189-4076-8cc3-b3f0018ae3c0" xlink:href="cccc-20231231.xsd#cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees_6d3bd792-3189-4076-8cc3-b3f0018ae3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods_ce7a91b9-eedd-43db-b418-b1e7d77c0664" xlink:href="cccc-20231231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods_ce7a91b9-eedd-43db-b418-b1e7d77c0664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_97dee2dd-ce32-43d1-8fd3-6c4de92dbd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_97dee2dd-ce32-43d1-8fd3-6c4de92dbd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_26aa8a8d-0d21-4c8a-9243-0a88b7ec8281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84a7343d-66a6-405a-b697-f64fa822de77" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_26aa8a8d-0d21-4c8a-9243-0a88b7ec8281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ed18d5e6-26b5-4fed-beb3-38c708ac5a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_acd11dc0-a277-492f-8198-f56d12dffcab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ed18d5e6-26b5-4fed-beb3-38c708ac5a87" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_acd11dc0-a277-492f-8198-f56d12dffcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_23c47c7b-8f38-4c4f-ad4b-4c2fe2585ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_acd11dc0-a277-492f-8198-f56d12dffcab" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_23c47c7b-8f38-4c4f-ad4b-4c2fe2585ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_577787ad-a31a-445c-b99e-63fd101cbfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_23c47c7b-8f38-4c4f-ad4b-4c2fe2585ac3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_577787ad-a31a-445c-b99e-63fd101cbfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c0960c09-6e3d-453b-b8ab-4b25619a1625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577787ad-a31a-445c-b99e-63fd101cbfb5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c0960c09-6e3d-453b-b8ab-4b25619a1625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_36bd5f6f-20c2-4ccf-a50d-ae7662032d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577787ad-a31a-445c-b99e-63fd101cbfb5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_36bd5f6f-20c2-4ccf-a50d-ae7662032d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_baa80ea3-600c-4934-9137-6bc22791b0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_acd11dc0-a277-492f-8198-f56d12dffcab" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_baa80ea3-600c-4934-9137-6bc22791b0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_62079fc5-33af-49c2-a00d-c449ac9f3585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_baa80ea3-600c-4934-9137-6bc22791b0cc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_62079fc5-33af-49c2-a00d-c449ac9f3585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationSummaryofstockoptionactivityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f7765e8-83bb-4ce2-b3ce-70f85cde73b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3392eb66-5497-48a7-aa7b-cbbc8122dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f7765e8-83bb-4ce2-b3ce-70f85cde73b7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3392eb66-5497-48a7-aa7b-cbbc8122dcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bcba7767-140c-447d-97a8-6e13d52357d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3392eb66-5497-48a7-aa7b-cbbc8122dcb0" xlink:to="loc_us-gaap_PlanNameAxis_bcba7767-140c-447d-97a8-6e13d52357d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_70c7012b-f8a0-426d-b2cf-5cf76cd36ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_bcba7767-140c-447d-97a8-6e13d52357d8" xlink:to="loc_us-gaap_PlanNameDomain_70c7012b-f8a0-426d-b2cf-5cf76cd36ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_38b1c81e-0151-4ede-b1c8-20069e3dd544" xlink:href="cccc-20231231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_70c7012b-f8a0-426d-b2cf-5cf76cd36ef0" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_38b1c81e-0151-4ede-b1c8-20069e3dd544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3392eb66-5497-48a7-aa7b-cbbc8122dcb0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3ce98af2-d012-4ca4-9b4b-dc39c483e7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3ce98af2-d012-4ca4-9b4b-dc39c483e7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3d8d216f-0524-4902-8cec-6b622ce6aa31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3d8d216f-0524-4902-8cec-6b622ce6aa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7bdbf8f9-d66f-400f-b178-2f397f6f4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7bdbf8f9-d66f-400f-b178-2f397f6f4bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f538d31a-05f7-4af1-adf2-5d488dabcddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f538d31a-05f7-4af1-adf2-5d488dabcddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a1fd99a5-1e6b-4918-832c-a5d658824f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_947a0564-77f8-485c-97d0-fe30e559e63b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a1fd99a5-1e6b-4918-832c-a5d658824f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fde34c1c-d56f-4e62-99c6-9c5e47709cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fde34c1c-d56f-4e62-99c6-9c5e47709cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c48f19b0-182f-4599-b130-ecd41bb18595" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c48f19b0-182f-4599-b130-ecd41bb18595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_edf14b17-334a-42e0-9de9-06668b9ae190" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_edf14b17-334a-42e0-9de9-06668b9ae190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cbfbc4ed-55ff-49f3-a865-588f9de2b400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cbfbc4ed-55ff-49f3-a865-588f9de2b400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1b9d701b-a274-4007-8efe-94c2d459f8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1b9d701b-a274-4007-8efe-94c2d459f8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9026276a-76cb-44d9-b9ea-64cad5c60173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9026276a-76cb-44d9-b9ea-64cad5c60173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b7a1e3a-6648-4d3b-bbde-01c6e0581eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7d3cf767-6167-4492-86a8-a25080b349d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b7a1e3a-6648-4d3b-bbde-01c6e0581eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8e971bde-86d9-40f4-baf7-91b631ccf414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8e971bde-86d9-40f4-baf7-91b631ccf414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_10981462-060b-4749-a824-85d7cc2dff2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_10981462-060b-4749-a824-85d7cc2dff2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3c793692-1424-41db-8941-f1ed079e1b4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_78dcfcda-59fe-4bb5-bf54-1663328ef0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_78dcfcda-59fe-4bb5-bf54-1663328ef0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40f1e965-9b1d-4878-a617-1b6c2e96f074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40f1e965-9b1d-4878-a617-1b6c2e96f074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_afe5429d-768f-4d72-a215-79c0f8da0fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_afe5429d-768f-4d72-a215-79c0f8da0fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cb3f5f9c-3dae-4ab4-9d56-e17f3985da6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cb3f5f9c-3dae-4ab4-9d56-e17f3985da6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2d69b2fb-436f-410e-8f98-6c1f8584574b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2d69b2fb-436f-410e-8f98-6c1f8584574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2b3a1337-a892-47fd-ad65-8ce75c397d44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b84c8e36-a593-4c50-9c27-56d8e887927f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2b3a1337-a892-47fd-ad65-8ce75c397d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bc59a4d3-2d9d-473c-8b1a-2be95895a366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c760fb9-a605-41b8-aae5-b000c8c63c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bc59a4d3-2d9d-473c-8b1a-2be95895a366" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c760fb9-a605-41b8-aae5-b000c8c63c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_660cc8c1-ad7b-4965-b994-ac3f89546085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c760fb9-a605-41b8-aae5-b000c8c63c5c" xlink:to="loc_us-gaap_PlanNameAxis_660cc8c1-ad7b-4965-b994-ac3f89546085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5dc99972-161e-4a7c-a6aa-d8de2f2d52d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_660cc8c1-ad7b-4965-b994-ac3f89546085" xlink:to="loc_us-gaap_PlanNameDomain_5dc99972-161e-4a7c-a6aa-d8de2f2d52d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_1c1422e8-b896-4d24-a136-45884d9ab3b5" xlink:href="cccc-20231231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5dc99972-161e-4a7c-a6aa-d8de2f2d52d0" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_1c1422e8-b896-4d24-a136-45884d9ab3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1abe203-770b-4da3-9743-33f50f2bab00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c760fb9-a605-41b8-aae5-b000c8c63c5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1abe203-770b-4da3-9743-33f50f2bab00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a048dd84-1555-46a6-8163-86c8d5c5f784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1abe203-770b-4da3-9743-33f50f2bab00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a048dd84-1555-46a6-8163-86c8d5c5f784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db703af3-0369-4c81-9f86-4279cb4b4678" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1abe203-770b-4da3-9743-33f50f2bab00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db703af3-0369-4c81-9f86-4279cb4b4678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab83c04c-494d-4703-8ed5-014b55d51d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48373e1-d76a-4d93-bb70-9d06a58ae373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab83c04c-494d-4703-8ed5-014b55d51d4b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48373e1-d76a-4d93-bb70-9d06a58ae373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b35104a1-e3fc-46b6-834b-4751afe9164b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48373e1-d76a-4d93-bb70-9d06a58ae373" xlink:to="loc_us-gaap_PlanNameAxis_b35104a1-e3fc-46b6-834b-4751afe9164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c41c5373-6806-411c-b647-c257a3d59789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b35104a1-e3fc-46b6-834b-4751afe9164b" xlink:to="loc_us-gaap_PlanNameDomain_c41c5373-6806-411c-b647-c257a3d59789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_3b1652d0-253a-468a-a4d2-445e644a3635" xlink:href="cccc-20231231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c41c5373-6806-411c-b647-c257a3d59789" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_3b1652d0-253a-468a-a4d2-445e644a3635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_353ce56a-ee14-4140-bde3-45005f5a1629" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48373e1-d76a-4d93-bb70-9d06a58ae373" xlink:to="loc_srt_RangeAxis_353ce56a-ee14-4140-bde3-45005f5a1629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13bc755f-2d95-4a67-9423-9b3a70f96df0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_353ce56a-ee14-4140-bde3-45005f5a1629" xlink:to="loc_srt_RangeMember_13bc755f-2d95-4a67-9423-9b3a70f96df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_44d5ca68-20fd-414f-a7d9-1df612ed3872" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13bc755f-2d95-4a67-9423-9b3a70f96df0" xlink:to="loc_srt_MinimumMember_44d5ca68-20fd-414f-a7d9-1df612ed3872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_62c167bb-16fa-45b7-a2b9-f35b564a8462" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13bc755f-2d95-4a67-9423-9b3a70f96df0" xlink:to="loc_srt_MaximumMember_62c167bb-16fa-45b7-a2b9-f35b564a8462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48373e1-d76a-4d93-bb70-9d06a58ae373" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60bc8d7f-13f3-4661-a0c4-d4b7a472ba47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60bc8d7f-13f3-4661-a0c4-d4b7a472ba47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_7451b0b9-fb06-4c67-8763-3b8757726e62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_7451b0b9-fb06-4c67-8763-3b8757726e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_892e4d71-5ee3-4f38-81e9-d2a4c729143a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_892e4d71-5ee3-4f38-81e9-d2a4c729143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c5713da0-5a93-4c3f-9fd7-051441fc16e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c5713da0-5a93-4c3f-9fd7-051441fc16e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_afbda13d-dcb3-457c-ae46-d95574cfe352" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_afbda13d-dcb3-457c-ae46-d95574cfe352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0967251c-2ca8-47db-b394-740f38358c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_472a7848-29d4-4d38-a99f-8ca85c084f4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0967251c-2ca8-47db-b394-740f38358c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofRSUactivityDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#StockbasedcompensationSummaryofRSUactivityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofRSUactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c070521-4993-4dfd-8954-f3833b5cacd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1df5dbf4-f4b1-4659-b465-a4e071cefea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c070521-4993-4dfd-8954-f3833b5cacd2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1df5dbf4-f4b1-4659-b465-a4e071cefea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9825743-7248-4202-9a6c-cd63b55094bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1df5dbf4-f4b1-4659-b465-a4e071cefea7" xlink:to="loc_us-gaap_AwardTypeAxis_a9825743-7248-4202-9a6c-cd63b55094bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3857a513-3c69-48f9-a6c7-2d0a3d661559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a9825743-7248-4202-9a6c-cd63b55094bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3857a513-3c69-48f9-a6c7-2d0a3d661559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bdbd5ea6-facc-41b2-9827-641b4d227161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3857a513-3c69-48f9-a6c7-2d0a3d661559" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bdbd5ea6-facc-41b2-9827-641b4d227161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TimeBasedRestrictedStockUnitsMember_81ce24bc-cc73-4ab8-8d21-f5c56176009a" xlink:href="cccc-20231231.xsd#cccc_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3857a513-3c69-48f9-a6c7-2d0a3d661559" xlink:to="loc_cccc_TimeBasedRestrictedStockUnitsMember_81ce24bc-cc73-4ab8-8d21-f5c56176009a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22bb6c51-615c-473b-8fda-2e34f682d706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1df5dbf4-f4b1-4659-b465-a4e071cefea7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22bb6c51-615c-473b-8fda-2e34f682d706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22bb6c51-615c-473b-8fda-2e34f682d706" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2336a618-bcd9-489f-a174-e2f011453faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2336a618-bcd9-489f-a174-e2f011453faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fa0628fb-2b26-48a9-9e95-2b02533410c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fa0628fb-2b26-48a9-9e95-2b02533410c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a9e467b-194a-4269-9a62-f615e7feb64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a9e467b-194a-4269-9a62-f615e7feb64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aed03605-4377-4ba7-b1bb-ebc52da56de2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aed03605-4377-4ba7-b1bb-ebc52da56de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e939c122-a269-4d67-80d1-353936f7e7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1a9e753f-3f14-45f2-8095-dd325c31e2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e939c122-a269-4d67-80d1-353936f7e7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22bb6c51-615c-473b-8fda-2e34f682d706" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ad243eea-c0ba-4015-a4fa-ffbbfe10d9da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ad243eea-c0ba-4015-a4fa-ffbbfe10d9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d2827326-fd6c-4eb2-acbd-16458580c414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d2827326-fd6c-4eb2-acbd-16458580c414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d1b6a435-c8b6-4ffe-a288-2a8d748b5e23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d1b6a435-c8b6-4ffe-a288-2a8d748b5e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_300a6be2-4bfd-4ce7-8b2b-b0409839da39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_300a6be2-4bfd-4ce7-8b2b-b0409839da39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7b2f242b-3d6e-4783-af8b-e040a8f77a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_79973626-e5c5-4b54-bed3-c8d3d22ac264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7b2f242b-3d6e-4783-af8b-e040a8f77a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_46f19758-1d3e-44e4-b16b-4765f9a2fa35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22bb6c51-615c-473b-8fda-2e34f682d706" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_46f19758-1d3e-44e4-b16b-4765f9a2fa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesSummaryofincometaxbenefitexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1cb2f0c0-bfd5-49cc-900e-f3781e73faa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1cb2f0c0-bfd5-49cc-900e-f3781e73faa8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_cbfcdd0a-dd39-4503-a98b-c7675e15d769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_cbfcdd0a-dd39-4503-a98b-c7675e15d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4034fa4f-384d-4fb2-a495-0a16bd73f90d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4034fa4f-384d-4fb2-a495-0a16bd73f90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_320cc86a-4d8e-4d69-b26f-d31bcf5ac487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_320cc86a-4d8e-4d69-b26f-d31bcf5ac487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2005d4cd-d32b-4e3d-85ee-77c28ef0cb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1c50a223-d071-47d8-afac-7b19f45567ea" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2005d4cd-d32b-4e3d-85ee-77c28ef0cb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cd81bfee-ca79-4f4f-8dc0-6b2dfce57586" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1cb2f0c0-bfd5-49cc-900e-f3781e73faa8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cd81bfee-ca79-4f4f-8dc0-6b2dfce57586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0463ea77-eea8-4fd9-b1bd-d5cf0e2f99e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cd81bfee-ca79-4f4f-8dc0-6b2dfce57586" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0463ea77-eea8-4fd9-b1bd-d5cf0e2f99e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8fcfa8ac-dc0c-47e1-9ee0-65cfbe23f467" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cd81bfee-ca79-4f4f-8dc0-6b2dfce57586" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8fcfa8ac-dc0c-47e1-9ee0-65cfbe23f467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7faa1307-88e3-4a16-9452-9335f57a7557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cd81bfee-ca79-4f4f-8dc0-6b2dfce57586" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7faa1307-88e3-4a16-9452-9335f57a7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9dd7919a-12da-4af4-bebb-2e166070fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1cb2f0c0-bfd5-49cc-900e-f3781e73faa8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9dd7919a-12da-4af4-bebb-2e166070fd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesScheduleofeffectiveincometaxratereconciliationDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_772ced8d-3ac9-4fe3-9594-9676e9e90f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_772ced8d-3ac9-4fe3-9594-9676e9e90f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_553a6ce0-eb2f-48d3-a149-ee52f410d1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_553a6ce0-eb2f-48d3-a149-ee52f410d1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_9ae9d95b-a0e0-41bc-a284-78d4532182b4" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_9ae9d95b-a0e0-41bc-a284-78d4532182b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_bfa23558-6328-433a-ac4f-463ad1c93dad" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_bfa23558-6328-433a-ac4f-463ad1c93dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_a2dc51e6-ce6b-4938-aef5-878bbc3e2055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_a2dc51e6-ce6b-4938-aef5-878bbc3e2055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax_892a7b1a-c5da-46ae-ad11-af08c40a8ea4" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax_892a7b1a-c5da-46ae-ad11-af08c40a8ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_44205407-6091-4d03-a3fc-0df42824abe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_44205407-6091-4d03-a3fc-0df42824abe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_f9a53e64-5134-4c37-8f35-d6a887b67679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_f9a53e64-5134-4c37-8f35-d6a887b67679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c3d52db6-952c-4d5a-9a21-4da94668ccbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05f1b149-89e0-42c7-8a9a-598f9c3dcbd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c3d52db6-952c-4d5a-9a21-4da94668ccbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0ace004d-2258-401f-abf9-d1732966231a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ace004d-2258-401f-abf9-d1732966231a" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4a0b1550-2df1-44b2-8e06-1efe5a70bf10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4a0b1550-2df1-44b2-8e06-1efe5a70bf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_9f35c364-ee84-44c5-a24c-097cd146569f" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_9f35c364-ee84-44c5-a24c-097cd146569f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_0d65ec59-f7fc-4658-835b-a720e12de5a6" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_0d65ec59-f7fc-4658-835b-a720e12de5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_f963af81-bfcd-406b-bb31-54d916f83918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_f963af81-bfcd-406b-bb31-54d916f83918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5dcc824f-eaa9-4ada-84bc-6a9c84341a59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5dcc824f-eaa9-4ada-84bc-6a9c84341a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_4a7178eb-b2ab-417c-b5c5-d9e9a8c77157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_4a7178eb-b2ab-417c-b5c5-d9e9a8c77157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_36ebb7e5-6e2e-4a7a-a509-e2efdf9b4fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_36ebb7e5-6e2e-4a7a-a509-e2efdf9b4fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_8070d202-96a5-41e1-a970-7664cd9d86fa" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsCapitalizedStartUpCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_8070d202-96a5-41e1-a970-7664cd9d86fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_7745e14b-1c9b-45db-bbf4-7de0bbc35f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_7745e14b-1c9b-45db-bbf4-7de0bbc35f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5f31574a-ff63-4961-8498-b9ea8ed69256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5f31574a-ff63-4961-8498-b9ea8ed69256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5f1a7207-6a84-4a03-a26d-c6dfa420606e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6770e20d-8a16-484d-9731-fa1bc7c947c2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5f1a7207-6a84-4a03-a26d-c6dfa420606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6dae63b3-5629-4d49-9cab-50ca0f21ea10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ace004d-2258-401f-abf9-d1732966231a" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6dae63b3-5629-4d49-9cab-50ca0f21ea10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_41e20975-b4ce-4e79-a045-729e1b2c2125" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6dae63b3-5629-4d49-9cab-50ca0f21ea10" xlink:to="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_41e20975-b4ce-4e79-a045-729e1b2c2125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_44692e5e-cb61-4298-a24a-15505761d856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6dae63b3-5629-4d49-9cab-50ca0f21ea10" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_44692e5e-cb61-4298-a24a-15505761d856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7e50cbef-5b5c-431d-ab10-cba8463442d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ace004d-2258-401f-abf9-d1732966231a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7e50cbef-5b5c-431d-ab10-cba8463442d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_fe63313a-038b-4753-8e39-1e0145d54a46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ace004d-2258-401f-abf9-d1732966231a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_fe63313a-038b-4753-8e39-1e0145d54a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0ddbb4a5-a014-4366-83bb-61840213139f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:href="cccc-20231231.xsd#cccc_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ddbb4a5-a014-4366-83bb-61840213139f" xlink:to="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4db718fe-52de-4e0d-8a8e-8f8ed73a2193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4db718fe-52de-4e0d-8a8e-8f8ed73a2193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_eacb07ee-b252-479f-9e1c-b6ead8f57999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4db718fe-52de-4e0d-8a8e-8f8ed73a2193" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_eacb07ee-b252-479f-9e1c-b6ead8f57999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_44ff0c0e-5a64-4986-a4db-aba19b34b7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_eacb07ee-b252-479f-9e1c-b6ead8f57999" xlink:to="loc_us-gaap_DomesticCountryMember_44ff0c0e-5a64-4986-a4db-aba19b34b7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7b40c7d5-4ef3-462b-9055-2669fa689667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_eacb07ee-b252-479f-9e1c-b6ead8f57999" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7b40c7d5-4ef3-462b-9055-2669fa689667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_e94760ef-121c-495e-9e0d-458e7351a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_e94760ef-121c-495e-9e0d-458e7351a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_b20c4db6-37a5-4e3f-b358-e23b6861355f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_e94760ef-121c-495e-9e0d-458e7351a1ef" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_b20c4db6-37a5-4e3f-b358-e23b6861355f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_7457a81f-796b-49c0-b5e5-4f177b111f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_b20c4db6-37a5-4e3f-b358-e23b6861355f" xlink:to="loc_us-gaap_ResearchMember_7457a81f-796b-49c0-b5e5-4f177b111f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_374d3be5-802e-4c40-a35a-cedf46cca82b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_374d3be5-802e-4c40-a35a-cedf46cca82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_20038e27-fdf4-4a4a-ba1a-d6bbd48abe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_374d3be5-802e-4c40-a35a-cedf46cca82b" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_20038e27-fdf4-4a4a-ba1a-d6bbd48abe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_d7854dc8-8723-4439-a933-2b9351276a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_20038e27-fdf4-4a4a-ba1a-d6bbd48abe6f" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_d7854dc8-8723-4439-a933-2b9351276a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:href="cccc-20231231.xsd#cccc_IncomeTaxLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_f053e09d-0f68-459b-a083-0cfb78a48e12" xlink:to="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_de69b54a-0337-4160-81e8-2edb80460658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_de69b54a-0337-4160-81e8-2edb80460658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f2ff0d6f-0abd-40f1-832e-14be9d4e03eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f2ff0d6f-0abd-40f1-832e-14be9d4e03eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_c2d9d5b9-43f0-4b5c-b542-5d4096daf09b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_c2d9d5b9-43f0-4b5c-b542-5d4096daf09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_4577c49e-0412-487e-8554-edc58e46d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_4577c49e-0412-487e-8554-edc58e46d2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent_fa6f74ff-ad1a-4dc8-91bb-93e05678fbc0" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent_fa6f74ff-ad1a-4dc8-91bb-93e05678fbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_017ca20f-9103-4b73-9a9e-dbf83b224a41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_017ca20f-9103-4b73-9a9e-dbf83b224a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_60f1d65f-9c10-48ca-a2a7-7853986aeef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_60f1d65f-9c10-48ca-a2a7-7853986aeef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges_c0ad46f2-23af-4b2e-850e-57a14f42ce93" xlink:href="cccc-20231231.xsd#cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges_c0ad46f2-23af-4b2e-850e-57a14f42ce93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd439100-1525-438b-8c5d-3048e863a0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_c88ca3ec-3923-4dfa-9cdd-9bf0a4e4516d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd439100-1525-438b-8c5d-3048e863a0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetlosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_96cde04d-ce01-461c-95b8-167aea9d8e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_807ed791-d256-4f1f-9327-9164532c9230" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_96cde04d-ce01-461c-95b8-167aea9d8e94" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_807ed791-d256-4f1f-9327-9164532c9230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e19aecd-182b-443f-99b2-8c35210b4d27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_807ed791-d256-4f1f-9327-9164532c9230" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e19aecd-182b-443f-99b2-8c35210b4d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_71bb9b37-7374-4202-945b-1f63ef919972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e19aecd-182b-443f-99b2-8c35210b4d27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_71bb9b37-7374-4202-945b-1f63ef919972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionsToPurchaseCommonStockMember_74708597-6ed1-4e1d-9e22-cbd63d6fa4f2" xlink:href="cccc-20231231.xsd#cccc_OptionsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_71bb9b37-7374-4202-945b-1f63ef919972" xlink:to="loc_cccc_OptionsToPurchaseCommonStockMember_74708597-6ed1-4e1d-9e22-cbd63d6fa4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cd5ef027-6bd3-4553-b8a1-e0727d08f943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_807ed791-d256-4f1f-9327-9164532c9230" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cd5ef027-6bd3-4553-b8a1-e0727d08f943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_abda5065-eeae-441d-a6cb-b2f08cfd873c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cd5ef027-6bd3-4553-b8a1-e0727d08f943" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_abda5065-eeae-441d-a6cb-b2f08cfd873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetlosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#NetlosspershareScheduleofbasicanddilutedlosspershareDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetlosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_da8bc48f-fec6-4023-bb6d-841aff0fd938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_4bb853b6-b586-4615-953e-a10af989f900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da8bc48f-fec6-4023-bb6d-841aff0fd938" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_4bb853b6-b586-4615-953e-a10af989f900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e333d596-facc-450f-97ba-44d7d2e39be8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_4bb853b6-b586-4615-953e-a10af989f900" xlink:to="loc_us-gaap_NetIncomeLoss_e333d596-facc-450f-97ba-44d7d2e39be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_009fb13a-0bd5-4a21-af76-26f3d03af0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da8bc48f-fec6-4023-bb6d-841aff0fd938" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_009fb13a-0bd5-4a21-af76-26f3d03af0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_30899aa4-9f9c-4cc5-ba9c-45b87105a158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_009fb13a-0bd5-4a21-af76-26f3d03af0a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_30899aa4-9f9c-4cc5-ba9c-45b87105a158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31877447-39a1-416f-b542-fa50cf3c9faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_009fb13a-0bd5-4a21-af76-26f3d03af0a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31877447-39a1-416f-b542-fa50cf3c9faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9ce1ca4a-bc7a-4191-aede-bfe815d59a57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da8bc48f-fec6-4023-bb6d-841aff0fd938" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9ce1ca4a-bc7a-4191-aede-bfe815d59a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2ed32100-2de2-4da8-ae51-1c986dbb7ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da8bc48f-fec6-4023-bb6d-841aff0fd938" xlink:to="loc_us-gaap_EarningsPerShareBasic_2ed32100-2de2-4da8-ae51-1c986dbb7ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/DefinedcontributionplanDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#DefinedcontributionplanDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/DefinedcontributionplanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_71b280f0-53bc-4ba8-a3cb-9ab629a96f10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_87202425-7bcb-4d54-b3b1-10b94e4d44b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_71b280f0-53bc-4ba8-a3cb-9ab629a96f10" xlink:to="loc_us-gaap_DefinedContributionPlanTable_87202425-7bcb-4d54-b3b1-10b94e4d44b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3d09f145-ed07-4024-80e6-019f5d3fef11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_87202425-7bcb-4d54-b3b1-10b94e4d44b0" xlink:to="loc_srt_RangeAxis_3d09f145-ed07-4024-80e6-019f5d3fef11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf84376c-d614-4d7f-b0fe-0da03cafdc36" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3d09f145-ed07-4024-80e6-019f5d3fef11" xlink:to="loc_srt_RangeMember_cf84376c-d614-4d7f-b0fe-0da03cafdc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12920c8c-8e42-4602-acfc-d2700a920825" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cf84376c-d614-4d7f-b0fe-0da03cafdc36" xlink:to="loc_srt_MaximumMember_12920c8c-8e42-4602-acfc-d2700a920825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_87202425-7bcb-4d54-b3b1-10b94e4d44b0" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_687bdd65-afa6-4c9b-a41c-050af3719e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_687bdd65-afa6-4c9b-a41c-050af3719e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_36ffee1c-11fe-4605-99c2-49a2d72b88c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_36ffee1c-11fe-4605-99c2-49a2d72b88c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_9e8ac6d2-3062-4879-99ab-e0744959ed41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_9e8ac6d2-3062-4879-99ab-e0744959ed41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfEmployeesGrossPay_eaab204a-373c-4337-be34-ce2cbf1909b7" xlink:href="cccc-20231231.xsd#cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfEmployeesGrossPay"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfEmployeesGrossPay_eaab204a-373c-4337-be34-ce2cbf1909b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfMatch_4ac48980-6b6d-4676-bdfa-0426cab35242" xlink:href="cccc-20231231.xsd#cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfMatch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_cccc_DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfMatch_4ac48980-6b6d-4676-bdfa-0426cab35242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0bf75760-03ea-4ba2-8fb1-a6642aad011e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_38f1683b-ab65-46ee-9a1a-80fdce389823" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0bf75760-03ea-4ba2-8fb1-a6642aad011e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#SubsequenteventsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SubsequenteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7871b0d0-44b9-46a0-ae91-57c5dc64baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1efa1f69-fc36-4c61-9f4b-65da897185cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7871b0d0-44b9-46a0-ae91-57c5dc64baf6" xlink:to="loc_us-gaap_SubsequentEventTable_1efa1f69-fc36-4c61-9f4b-65da897185cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_843b340b-2443-422c-8861-7eb0396a4c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1efa1f69-fc36-4c61-9f4b-65da897185cb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_843b340b-2443-422c-8861-7eb0396a4c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca031ac3-a4ca-48d5-9ca3-a4b4f6a9eb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_843b340b-2443-422c-8861-7eb0396a4c3b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca031ac3-a4ca-48d5-9ca3-a4b4f6a9eb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7f9c31a3-9bfb-4ec3-bd89-6d355f9155a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ca031ac3-a4ca-48d5-9ca3-a4b4f6a9eb4e" xlink:to="loc_us-gaap_SubsequentEventMember_7f9c31a3-9bfb-4ec3-bd89-6d355f9155a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8c090279-f38c-4465-bda0-30670d0ab33a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1efa1f69-fc36-4c61-9f4b-65da897185cb" xlink:to="loc_us-gaap_SubsequentEventLineItems_8c090279-f38c-4465-bda0-30670d0ab33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4f9119ab-d1f9-48ba-9cd4-855cc9701152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8c090279-f38c-4465-bda0-30670d0ab33a" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4f9119ab-d1f9-48ba-9cd4-855cc9701152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_6b7f255c-9e1b-4b6f-b09a-149acf711b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8c090279-f38c-4465-bda0-30670d0ab33a" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_6b7f255c-9e1b-4b6f-b09a-149acf711b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
